Introduction  ||| S:24 E:45 ||| NN
The  ||| S:45 E:49 ||| DT
study  ||| S:49 E:55 ||| NN
of  ||| S:55 E:58 ||| IN
gene  ||| S:58 E:63 ||| NN
function  ||| S:63 E:72 ||| NN
has  ||| S:72 E:76 ||| VBZ
been  ||| S:76 E:81 ||| VBN
greatly  ||| S:81 E:89 ||| RB
advanced  ||| S:89 E:106 ||| VBN
through  ||| S:106 E:114 ||| IN
the  ||| S:114 E:118 ||| DT
use  ||| S:118 E:122 ||| NN
of  ||| S:122 E:125 ||| IN
transgenic  ||| S:125 E:136 ||| JJ
mice ||| S:136 E:140 ||| NNS
.  ||| S:140 E:142 ||| .
Over-expression  ||| S:142 E:158 ||| NNP
and  ||| S:158 E:170 ||| CC
ectopic  ||| S:170 E:178 ||| JJ
expression  ||| S:178 E:189 ||| NN
of  ||| S:189 E:192 ||| IN
transgenes ||| S:192 E:202 ||| NN
,  ||| S:202 E:204 ||| ,
as  ||| S:204 E:207 ||| RB
well  ||| S:207 E:212 ||| RB
as  ||| S:212 E:215 ||| IN
the  ||| S:215 E:219 ||| DT
expression  ||| S:219 E:238 ||| NN
of  ||| S:238 E:241 ||| IN
genetic  ||| S:241 E:249 ||| JJ
variants ||| S:249 E:257 ||| NN
,  ||| S:257 E:259 ||| ,
has  ||| S:259 E:263 ||| VBZ
facilitated  ||| S:263 E:275 ||| VBG
the  ||| S:275 E:279 ||| DT
deciphering  ||| S:279 E:291 ||| NN
of  ||| S:291 E:302 ||| IN
complex  ||| S:302 E:310 ||| JJ
cellular  ||| S:310 E:319 ||| JJ
processes  ||| S:319 E:329 ||| NNS
as  ||| S:329 E:332 ||| IN
well  ||| S:332 E:337 ||| RB
as  ||| S:337 E:340 ||| IN
the  ||| S:340 E:344 ||| DT
generation  ||| S:344 E:355 ||| NN
of  ||| S:355 E:366 ||| IN
animal  ||| S:366 E:373 ||| JJ
models  ||| S:373 E:380 ||| NNS
of  ||| S:380 E:383 ||| IN
disease ||| S:383 E:390 ||| NN
.  ||| S:390 E:392 ||| .
More  ||| S:392 E:397 ||| RBR
recently ||| S:397 E:405 ||| RB
,  ||| S:405 E:407 ||| ,
transgenic  ||| S:407 E:418 ||| JJ
mice  ||| S:418 E:431 ||| NNS
have  ||| S:431 E:436 ||| VBP
also  ||| S:436 E:441 ||| RB
been  ||| S:441 E:446 ||| VBN
used  ||| S:446 E:451 ||| VBN
to  ||| S:451 E:454 ||| TO
express  ||| S:454 E:462 ||| VB
Cre  ||| S:462 E:466 ||| JJ
recombinase  ||| S:466 E:478 ||| NN
to  ||| S:478 E:481 ||| TO
mediate  ||| S:481 E:497 ||| VB
the  ||| S:497 E:501 ||| DT
conditional  ||| S:501 E:513 ||| JJ
deletion  ||| S:513 E:522 ||| NN
of  ||| S:522 E:534 ||| IN
loxP  ||| S:534 E:539 ||| JJ
-flanked  ||| S:539 E:548 ||| JJ
DNA  ||| S:548 E:552 ||| NN
sequences  ||| S:552 E:562 ||| NN
in  ||| S:562 E:573 ||| IN
specific  ||| S:573 E:582 ||| JJ
cell  ||| S:582 E:587 ||| NN
types  ||| S:587 E:602 ||| NNS
in  ||| S:602 E:605 ||| IN
vivo  ||| S:605 E:610 ||| NN
.  ||| S:610 E:612 ||| .
Traditional  ||| S:612 E:624 ||| JJ
methods  ||| S:624 E:632 ||| NNS
for  ||| S:632 E:644 ||| IN
generating  ||| S:644 E:655 ||| VBG
transgenic  ||| S:655 E:666 ||| JJ
mice  ||| S:666 E:671 ||| NNS
require  ||| S:671 E:679 ||| VBP
the  ||| S:679 E:683 ||| DT
availability  ||| S:683 E:696 ||| NN
of  ||| S:696 E:699 ||| IN
well  ||| S:699 E:712 ||| RB
characterized  ||| S:712 E:726 ||| VBN
transcriptional  ||| S:726 E:742 ||| JJ
regulatory  ||| S:742 E:753 ||| JJ
elements ||| S:753 E:761 ||| NNS
,  ||| S:761 E:771 ||| ,
promoters  ||| S:771 E:781 ||| NNS
or  ||| S:781 E:784 ||| CC
enhancers ||| S:784 E:793 ||| NN
,  ||| S:793 E:795 ||| ,
that  ||| S:795 E:800 ||| DT
direct  ||| S:800 E:807 ||| JJ
transgene  ||| S:807 E:817 ||| JJ
expression  ||| S:817 E:828 ||| NN
in  ||| S:828 E:839 ||| IN
specific  ||| S:839 E:848 ||| JJ
cell  ||| S:848 E:853 ||| NN
types ||| S:853 E:858 ||| NNS
.  ||| S:858 E:860 ||| .
For  ||| S:860 E:864 ||| IN
example ||| S:864 E:871 ||| NN
,  ||| S:871 E:882 ||| ,
Surfactant  ||| S:882 E:893 ||| NNP
protein  ||| S:893 E:901 ||| NN
C  ||| S:901 E:903 ||| NNP
regulatory  ||| S:903 E:922 ||| JJ
elements  ||| S:922 E:931 ||| NNS
have  ||| S:931 E:936 ||| VBP
been  ||| S:936 E:941 ||| VBN
used  ||| S:941 E:946 ||| VBN
extensively  ||| S:946 E:958 ||| RB
to  ||| S:958 E:961 ||| TO
drive  ||| S:961 E:967 ||| VB
high  ||| S:967 E:972 ||| JJ
level  ||| S:972 E:986 ||| NN
expression  ||| S:986 E:997 ||| NN
of  ||| S:997 E:1000 ||| IN
transgenes  ||| S:1000 E:1011 ||| NN
in  ||| S:1011 E:1014 ||| IN
the  ||| S:1014 E:1018 ||| DT
lung  ||| S:1018 E:1023 ||| NN
[  ||| S:1023 E:1025 ||| -LRB-
1 ||| S:1025 E:1026 ||| CD
,  ||| S:1026 E:1028 ||| ,
2 ||| S:1028 E:1029 ||| CD
,  ||| S:1029 E:1031 ||| ,
3 ||| S:1031 E:1032 ||| CD
,  ||| S:1032 E:1034 ||| ,
4 ||| S:1034 E:1035 ||| LS
] ||| S:1035 E:1036 ||| -RRB-
.  ||| S:1036 E:1046 ||| .
Similarly ||| S:1046 E:1055 ||| RB
,  ||| S:1055 E:1066 ||| ,
Transthyretin  ||| S:1066 E:1080 ||| NNP
regulatory  ||| S:1080 E:1091 ||| JJ
elements  ||| S:1091 E:1108 ||| NNS
confer  ||| S:1108 E:1115 ||| VBP
expression  ||| S:1115 E:1126 ||| NN
of  ||| S:1126 E:1129 ||| IN
transgenes  ||| S:1129 E:1140 ||| NN
in  ||| S:1140 E:1143 ||| IN
the  ||| S:1143 E:1147 ||| DT
liver  ||| S:1147 E:1153 ||| NN
[  ||| S:1153 E:1155 ||| -LRB-
5 ||| S:1155 E:1156 ||| CD
,  ||| S:1156 E:1158 ||| ,
6 ||| S:1158 E:1159 ||| CD
] ||| S:1159 E:1160 ||| -RRB-
.  ||| S:1160 E:1170 ||| .
Unfortunately ||| S:1170 E:1183 ||| RB
,  ||| S:1183 E:1185 ||| ,
the  ||| S:1185 E:1189 ||| DT
number  ||| S:1189 E:1196 ||| NN
well-characterized  ||| S:1196 E:1223 ||| FW
enhancers ||| S:1223 E:1232 ||| FW
/ ||| S:1232 E:1233 ||| FW
promoters  ||| S:1233 E:1243 ||| FW
available  ||| S:1243 E:1253 ||| JJ
for  ||| S:1253 E:1257 ||| IN
transgene  ||| S:1257 E:1267 ||| JJ
expression  ||| S:1267 E:1278 ||| NN
is  ||| S:1278 E:1289 ||| VBZ
limited ||| S:1289 E:1296 ||| VBN
.  ||| S:1296 E:1298 ||| .
This  ||| S:1298 E:1303 ||| DT
is  ||| S:1303 E:1306 ||| VBZ
due  ||| S:1306 E:1310 ||| JJ
to  ||| S:1310 E:1313 ||| TO
the  ||| S:1313 E:1317 ||| DT
fact  ||| S:1317 E:1322 ||| NN
that ||| S:1322 E:1326 ||| IN
,  ||| S:1326 E:1328 ||| ,
although  ||| S:1328 E:1346 ||| IN
in  ||| S:1346 E:1349 ||| IN
situ  ||| S:1349 E:1354 ||| JJ
hybridization  ||| S:1354 E:1368 ||| NN
and  ||| S:1368 E:1372 ||| CC
RNA  ||| S:1372 E:1384 ||| NNP
blotting  ||| S:1384 E:1393 ||| NN
techniques  ||| S:1393 E:1404 ||| NNS
can  ||| S:1404 E:1408 ||| MD
rapidly  ||| S:1408 E:1416 ||| RB
characterize  ||| S:1416 E:1429 ||| VB
the  ||| S:1429 E:1433 ||| DT
expression  ||| S:1433 E:1452 ||| NN
patterns  ||| S:1452 E:1461 ||| NNS
of  ||| S:1461 E:1464 ||| IN
genes ||| S:1464 E:1469 ||| NNS
,  ||| S:1469 E:1471 ||| ,
the  ||| S:1471 E:1475 ||| DT
identification  ||| S:1475 E:1490 ||| NN
of  ||| S:1490 E:1493 ||| IN
regulatory  ||| S:1493 E:1512 ||| JJ
elements  ||| S:1512 E:1521 ||| NNS
that  ||| S:1521 E:1526 ||| IN
control  ||| S:1526 E:1534 ||| NN
cell  ||| S:1534 E:1539 ||| NN
type-specific  ||| S:1539 E:1553 ||| JJ
expression  ||| S:1553 E:1564 ||| NN
in  ||| S:1564 E:1575 ||| IN
animals  ||| S:1575 E:1583 ||| NNS
is  ||| S:1583 E:1586 ||| VBZ
extremely  ||| S:1586 E:1596 ||| RB
laborious ||| S:1596 E:1605 ||| VBN
.  ||| S:1605 E:1607 ||| .
An  ||| S:1607 E:1610 ||| DT
additional  ||| S:1610 E:1621 ||| JJ
complication  ||| S:1621 E:1642 ||| NN
associated  ||| S:1642 E:1653 ||| VBN
with  ||| S:1653 E:1658 ||| IN
traditional  ||| S:1658 E:1670 ||| JJ
transgenic  ||| S:1670 E:1681 ||| JJ
approaches  ||| S:1681 E:1692 ||| NNS
is  ||| S:1692 E:1695 ||| VBZ
that  ||| S:1695 E:1708 ||| IN
the  ||| S:1708 E:1712 ||| DT
number  ||| S:1712 E:1719 ||| NN
and  ||| S:1719 E:1723 ||| CC
genomic  ||| S:1723 E:1731 ||| JJ
location  ||| S:1731 E:1740 ||| NN
of  ||| S:1740 E:1743 ||| IN
transgene  ||| S:1743 E:1753 ||| JJ
integration  ||| S:1753 E:1773 ||| NN
events  ||| S:1773 E:1780 ||| NNS
is  ||| S:1780 E:1783 ||| VBZ
random ||| S:1783 E:1789 ||| JJ
.  ||| S:1789 E:1791 ||| .
This  ||| S:1791 E:1796 ||| DT
can  ||| S:1796 E:1800 ||| MD
have  ||| S:1800 E:1805 ||| VB
a  ||| S:1805 E:1807 ||| DT
significant  ||| S:1807 E:1819 ||| JJ
impact  ||| S:1819 E:1826 ||| NN
on  ||| S:1826 E:1837 ||| IN
both  ||| S:1837 E:1842 ||| PDT
the  ||| S:1842 E:1846 ||| DT
level  ||| S:1846 E:1852 ||| NN
and  ||| S:1852 E:1856 ||| CC
site  ||| S:1856 E:1861 ||| NN
of  ||| S:1861 E:1864 ||| IN
transgene  ||| S:1864 E:1874 ||| JJ
expression ||| S:1874 E:1884 ||| NN
.  ||| S:1884 E:1886 ||| .
These  ||| S:1886 E:1900 ||| DT
problems  ||| S:1900 E:1909 ||| NNS
can  ||| S:1909 E:1913 ||| MD
be  ||| S:1913 E:1916 ||| VB
circumvented ||| S:1916 E:1928 ||| NNS
,  ||| S:1928 E:1930 ||| ,
however ||| S:1930 E:1937 ||| RB
,  ||| S:1937 E:1939 ||| ,
by  ||| S:1939 E:1942 ||| IN
utilizing  ||| S:1942 E:1960 ||| JJ
endogenous  ||| S:1960 E:1971 ||| JJ
regulatory  ||| S:1971 E:1982 ||| JJ
elements ||| S:1982 E:1990 ||| NNS
.  ||| S:1990 E:1992 ||| .
This  ||| S:1992 E:1997 ||| DT
can  ||| S:1997 E:2001 ||| MD
be  ||| S:2001 E:2004 ||| VB
achieved  ||| S:2004 E:2013 ||| VBN
by  ||| S:2013 E:2024 ||| IN
introducing  ||| S:2024 E:2036 ||| VBG
transgenes  ||| S:2036 E:2047 ||| NN
into  ||| S:2047 E:2052 ||| IN
defined  ||| S:2052 E:2060 ||| VBN
genomic  ||| S:2060 E:2068 ||| JJ
loci  ||| S:2068 E:2073 ||| NN
through  ||| S:2073 E:2089 ||| IN
homologous  ||| S:2089 E:2100 ||| JJ
recombination  ||| S:2100 E:2114 ||| NN
in  ||| S:2114 E:2117 ||| IN
ES  ||| S:2117 E:2120 ||| NNP
cells  ||| S:2120 E:2126 ||| NNS
( ||| S:2126 E:2127 ||| -LRB-
"knock-in ||| S:2127 E:2136 ||| NNP
" ||| S:2136 E:2137 ||| ''
)  ||| S:2137 E:2139 ||| -RRB-
[  ||| S:2139 E:2141 ||| -LRB-
7 ||| S:2141 E:2142 ||| CD
] ||| S:2142 E:2143 ||| -RRB-
.  ||| S:2143 E:2153 ||| .
While  ||| S:2153 E:2159 ||| IN
this  ||| S:2159 E:2164 ||| DT
approach  ||| S:2164 E:2173 ||| NN
requires  ||| S:2173 E:2182 ||| VBZ
knowledge  ||| S:2182 E:2192 ||| NN
of  ||| S:2192 E:2195 ||| IN
the  ||| S:2195 E:2199 ||| DT
gene  ||| S:2199 E:2212 ||| NN
expression  ||| S:2212 E:2223 ||| NN
pattern  ||| S:2223 E:2231 ||| NN
it  ||| S:2231 E:2234 ||| PRP
does  ||| S:2234 E:2239 ||| VBZ
not  ||| S:2239 E:2243 ||| RB
require  ||| S:2243 E:2251 ||| VB
any  ||| S:2251 E:2255 ||| DT
analysis  ||| S:2255 E:2264 ||| NN
of  ||| S:2264 E:2267 ||| IN
gene  ||| S:2267 E:2280 ||| NN
regulatory  ||| S:2280 E:2291 ||| JJ
elements ||| S:2291 E:2299 ||| NNS
.  ||| S:2299 E:2301 ||| .
Such  ||| S:2301 E:2306 ||| PDT
a  ||| S:2306 E:2308 ||| DT
"knock-in ||| S:2308 E:2317 ||| NN
"  ||| S:2317 E:2319 ||| ''
approach  ||| S:2319 E:2328 ||| NN
would ||| S:2328 E:2333 ||| MD
,  ||| S:2333 E:2335 ||| ,
in  ||| S:2335 E:2346 ||| IN
effect ||| S:2346 E:2352 ||| NN
,  ||| S:2352 E:2354 ||| ,
significantly  ||| S:2354 E:2368 ||| RB
increase  ||| S:2368 E:2377 ||| VB
the  ||| S:2377 E:2381 ||| DT
repertoire  ||| S:2381 E:2392 ||| NN
of  ||| S:2392 E:2395 ||| IN
regulatory  ||| S:2395 E:2414 ||| JJ
elements  ||| S:2414 E:2423 ||| NNS
available  ||| S:2423 E:2433 ||| JJ
to  ||| S:2433 E:2436 ||| TO
drive  ||| S:2436 E:2442 ||| VB
transgene  ||| S:2442 E:2452 ||| JJ
expression ||| S:2452 E:2462 ||| NN
.  ||| S:2462 E:2464 ||| .
Moreover ||| S:2464 E:2472 ||| RB
,  ||| S:2472 E:2482 ||| ,
it  ||| S:2482 E:2485 ||| PRP
ensures  ||| S:2485 E:2493 ||| VBZ
that  ||| S:2493 E:2498 ||| IN
a  ||| S:2498 E:2500 ||| DT
single  ||| S:2500 E:2507 ||| JJ
copy  ||| S:2507 E:2512 ||| NN
of  ||| S:2512 E:2515 ||| IN
the  ||| S:2515 E:2519 ||| DT
transgene  ||| S:2519 E:2529 ||| NN
is  ||| S:2529 E:2540 ||| VBZ
introduced  ||| S:2540 E:2551 ||| VBN
into  ||| S:2551 E:2556 ||| IN
a  ||| S:2556 E:2558 ||| DT
defined  ||| S:2558 E:2566 ||| VBN
genomic  ||| S:2566 E:2574 ||| JJ
location ||| S:2574 E:2582 ||| NN
.  ||| S:2582 E:2584 ||| .
The  ||| S:2584 E:2596 ||| DT
introduction  ||| S:2596 E:2609 ||| NN
of  ||| S:2609 E:2621 ||| IN
LacZ  ||| S:2621 E:2626 ||| JJ
into  ||| S:2626 E:2631 ||| IN
specific  ||| S:2631 E:2640 ||| JJ
genes  ||| S:2640 E:2646 ||| NNS
during  ||| S:2646 E:2653 ||| IN
the  ||| S:2653 E:2665 ||| DT
generation  ||| S:2665 E:2676 ||| NN
of  ||| S:2676 E:2679 ||| IN
knockout  ||| S:2679 E:2688 ||| JJ
mice  ||| S:2688 E:2693 ||| NNS
has  ||| S:2693 E:2697 ||| VBZ
demonstrated  ||| S:2697 E:2710 ||| VBN
that  ||| S:2710 E:2715 ||| IN
such  ||| S:2715 E:2720 ||| PDT
an  ||| S:2720 E:2731 ||| DT
approach  ||| S:2731 E:2740 ||| NN
can  ||| S:2740 E:2744 ||| MD
be  ||| S:2744 E:2747 ||| VB
successful  ||| S:2747 E:2758 ||| JJ
[  ||| S:2758 E:2760 ||| -LRB-
8 ||| S:2760 E:2761 ||| CD
,  ||| S:2761 E:2763 ||| ,
9 ||| S:2763 E:2764 ||| CD
] ||| S:2764 E:2765 ||| -RRB-
.  ||| S:2765 E:2767 ||| .
The  ||| S:2767 E:2771 ||| DT
downside ||| S:2771 E:2779 ||| NN
,  ||| S:2779 E:2781 ||| ,
however ||| S:2781 E:2788 ||| RB
,  ||| S:2788 E:2798 ||| ,
is  ||| S:2798 E:2801 ||| VBZ
that  ||| S:2801 E:2806 ||| IN
every  ||| S:2806 E:2812 ||| DT
individual  ||| S:2812 E:2823 ||| JJ
transgene  ||| S:2823 E:2833 ||| NNS
an  ||| S:2833 E:2836 ||| DT
investigator  ||| S:2836 E:2849 ||| NN
wishes  ||| S:2849 E:2864 ||| VBZ
to  ||| S:2864 E:2867 ||| TO
express  ||| S:2867 E:2875 ||| VB
must  ||| S:2875 E:2880 ||| MD
be  ||| S:2880 E:2883 ||| VB
independently  ||| S:2883 E:2897 ||| RB
targeted  ||| S:2897 E:2906 ||| VBN
to  ||| S:2906 E:2909 ||| TO
the  ||| S:2909 E:2913 ||| DT
chosen  ||| S:2913 E:2928 ||| VBN
genomic  ||| S:2928 E:2936 ||| JJ
locus ||| S:2936 E:2941 ||| NN
.  ||| S:2941 E:2943 ||| .
This  ||| S:2943 E:2948 ||| DT
can  ||| S:2948 E:2952 ||| MD
be  ||| S:2952 E:2955 ||| VB
tedious ||| S:2955 E:2962 ||| NNS
,  ||| S:2962 E:2964 ||| ,
especially  ||| S:2964 E:2975 ||| RB
if  ||| S:2975 E:2978 ||| IN
the  ||| S:2978 E:2982 ||| DT
rate  ||| S:2982 E:2995 ||| NN
of  ||| S:2995 E:2998 ||| IN
recombination  ||| S:2998 E:3012 ||| NN
at  ||| S:3012 E:3015 ||| IN
the  ||| S:3015 E:3019 ||| DT
chosen  ||| S:3019 E:3026 ||| VBN
genomic  ||| S:3026 E:3034 ||| JJ
locus  ||| S:3034 E:3040 ||| NN
is  ||| S:3040 E:3043 ||| VBZ
low ||| S:3043 E:3046 ||| JJ
.  ||| S:3046 E:3048 ||| .
Here ||| S:3048 E:3052 ||| RB
,  ||| S:3052 E:3062 ||| ,
we  ||| S:3062 E:3065 ||| PRP
describe  ||| S:3065 E:3074 ||| VBP
a  ||| S:3074 E:3076 ||| DT
simple  ||| S:3076 E:3083 ||| JJ
method  ||| S:3083 E:3090 ||| NN
that  ||| S:3090 E:3095 ||| WDT
allows  ||| S:3095 E:3102 ||| VBZ
transgenes  ||| S:3102 E:3113 ||| VBN
targeted  ||| S:3113 E:3130 ||| VBN
to  ||| S:3130 E:3133 ||| TO
a  ||| S:3133 E:3135 ||| DT
marked  ||| S:3135 E:3142 ||| JJ
genomic  ||| S:3142 E:3150 ||| JJ
locus  ||| S:3150 E:3156 ||| NN
to  ||| S:3156 E:3159 ||| TO
be  ||| S:3159 E:3162 ||| VB
selected  ||| S:3162 E:3171 ||| VBN
with  ||| S:3171 E:3176 ||| IN
extremely  ||| S:3176 E:3194 ||| RB
high  ||| S:3194 E:3199 ||| JJ
efficiency  ||| S:3199 E:3210 ||| NN
in  ||| S:3210 E:3213 ||| IN
ES  ||| S:3213 E:3216 ||| NNP
cells ||| S:3216 E:3221 ||| NNS
.  ||| S:3221 E:3223 ||| .
This  ||| S:3223 E:3228 ||| DT
approach  ||| S:3228 E:3237 ||| NN
is  ||| S:3237 E:3240 ||| VBZ
also  ||| S:3240 E:3253 ||| RB
appealing  ||| S:3253 E:3263 ||| VBG
because  ||| S:3263 E:3271 ||| IN
it  ||| S:3271 E:3274 ||| PRP
relies  ||| S:3274 E:3281 ||| VBZ
on  ||| S:3281 E:3284 ||| IN
reconstitution  ||| S:3284 E:3299 ||| NN
of  ||| S:3299 E:3302 ||| IN
active  ||| S:3302 E:3317 ||| JJ
neomycin  ||| S:3317 E:3326 ||| JJ
phosphotransferase  ||| S:3326 E:3345 ||| JJ
activity ||| S:3345 E:3353 ||| NN
,  ||| S:3353 E:3355 ||| ,
and  ||| S:3355 E:3359 ||| CC
so  ||| S:3359 E:3362 ||| RB
correctly  ||| S:3362 E:3380 ||| RB
targeted  ||| S:3380 E:3389 ||| VBN
ES  ||| S:3389 E:3392 ||| NNP
cell  ||| S:3392 E:3397 ||| NN
clones  ||| S:3397 E:3404 ||| NNS
can  ||| S:3404 E:3408 ||| MD
be  ||| S:3408 E:3411 ||| VB
simply  ||| S:3411 E:3418 ||| RB
selected  ||| S:3418 E:3427 ||| VBN
by  ||| S:3427 E:3430 ||| IN
growth  ||| S:3430 E:3437 ||| NN
in  ||| S:3437 E:3448 ||| IN
G418 ||| S:3448 E:3452 ||| CD
.  ||| S:3452 E:3476 ||| .
Results  ||| S:3476 E:3492 ||| NNP
Fig  ||| S:3492 E:3496 ||| NNP
1illustrates  ||| S:3496 E:3509 ||| CD
the  ||| S:3509 E:3513 ||| DT
overall  ||| S:3513 E:3521 ||| JJ
strategy  ||| S:3521 E:3530 ||| NN
that  ||| S:3530 E:3535 ||| IN
we  ||| S:3535 E:3538 ||| PRP
have  ||| S:3538 E:3543 ||| VBP
used  ||| S:3543 E:3556 ||| VBN
to  ||| S:3556 E:3559 ||| TO
introduce  ||| S:3559 E:3569 ||| VB
single  ||| S:3569 E:3576 ||| JJ
copy  ||| S:3576 E:3581 ||| NN
transgenes  ||| S:3581 E:3592 ||| NN
into  ||| S:3592 E:3597 ||| IN
a  ||| S:3597 E:3599 ||| DT
defined  ||| S:3599 E:3607 ||| VBN
genomic  ||| S:3607 E:3623 ||| JJ
locus ||| S:3623 E:3628 ||| NN
.  ||| S:3628 E:3630 ||| .
For  ||| S:3630 E:3634 ||| IN
convenience  ||| S:3634 E:3646 ||| NN
the  ||| S:3646 E:3650 ||| DT
procedure  ||| S:3650 E:3660 ||| NN
can  ||| S:3660 E:3664 ||| MD
be  ||| S:3664 E:3667 ||| VB
considered  ||| S:3667 E:3678 ||| VBN
in  ||| S:3678 E:3689 ||| IN
three  ||| S:3689 E:3695 ||| CD
distinct  ||| S:3695 E:3704 ||| JJ
steps ||| S:3704 E:3709 ||| NNS
.  ||| S:3709 E:3711 ||| .
First  ||| S:3711 E:3717 ||| RB
a  ||| S:3717 E:3719 ||| DT
specific  ||| S:3719 E:3728 ||| JJ
genomic  ||| S:3728 E:3736 ||| JJ
locus  ||| S:3736 E:3742 ||| NN
is  ||| S:3742 E:3753 ||| VBZ
chosen  ||| S:3753 E:3760 ||| VBN
based  ||| S:3760 E:3766 ||| VBN
on  ||| S:3766 E:3769 ||| IN
known  ||| S:3769 E:3775 ||| JJ
gene  ||| S:3775 E:3780 ||| NN
expression  ||| S:3780 E:3791 ||| NN
data ||| S:3791 E:3795 ||| NNS
.  ||| S:3795 E:3797 ||| .
In  ||| S:3797 E:3800 ||| IN
the  ||| S:3800 E:3804 ||| DT
example  ||| S:3804 E:3820 ||| NN
presented  ||| S:3820 E:3830 ||| VBD
here  ||| S:3830 E:3835 ||| RB
we  ||| S:3835 E:3838 ||| PRP
chose  ||| S:3838 E:3844 ||| VBD
the  ||| S:3844 E:3857 ||| DT
Hnf3  ||| S:3857 E:3862 ||| JJ
α  ||| S:3862 E:3864 ||| JJ
locus  ||| S:3864 E:3870 ||| NN
because  ||| S:3870 E:3878 ||| IN
Hnf3α  ||| S:3878 E:3884 ||| NNP
is  ||| S:3884 E:3895 ||| VBZ
expressed  ||| S:3895 E:3905 ||| VBN
throughout  ||| S:3905 E:3916 ||| IN
the  ||| S:3916 E:3920 ||| DT
embryonic  ||| S:3920 E:3930 ||| JJ
gut  ||| S:3930 E:3934 ||| NN
endoderm  ||| S:3934 E:3943 ||| NN
of  ||| S:3943 E:3946 ||| IN
the  ||| S:3946 E:3958 ||| DT
mouse  ||| S:3958 E:3964 ||| NN
and  ||| S:3964 E:3968 ||| CC
our  ||| S:3968 E:3972 ||| PRP$
ultimate  ||| S:3972 E:3981 ||| JJ
objective  ||| S:3981 E:3991 ||| NN
is  ||| S:3991 E:3994 ||| VBZ
to  ||| S:3994 E:3997 ||| TO
assess  ||| S:3997 E:4004 ||| VB
the  ||| S:4004 E:4008 ||| DT
function  ||| S:4008 E:4025 ||| NN
of  ||| S:4025 E:4028 ||| IN
transgenes  ||| S:4028 E:4039 ||| NN
expressed  ||| S:4039 E:4049 ||| VBD
in  ||| S:4049 E:4052 ||| IN
this  ||| S:4052 E:4057 ||| DT
tissue  ||| S:4057 E:4064 ||| NN
[  ||| S:4064 E:4066 ||| -LRB-
10 ||| S:4066 E:4068 ||| CD
,  ||| S:4068 E:4070 ||| ,
11 ||| S:4070 E:4072 ||| CD
,  ||| S:4072 E:4074 ||| ,
12 ||| S:4074 E:4076 ||| CD
,  ||| S:4076 E:4078 ||| ,
13 ||| S:4078 E:4080 ||| CD
] ||| S:4080 E:4081 ||| -RRB-
.  ||| S:4081 E:4091 ||| .
In  ||| S:4091 E:4094 ||| IN
addition ||| S:4094 E:4102 ||| NN
,  ||| S:4102 E:4104 ||| ,
mice  ||| S:4104 E:4109 ||| NNS
lacking  ||| S:4109 E:4117 ||| VBG
a  ||| S:4117 E:4119 ||| DT
single  ||| S:4119 E:4135 ||| JJ
Hnf3  ||| S:4135 E:4140 ||| CD
α  ||| S:4140 E:4142 ||| CD
allele  ||| S:4142 E:4149 ||| NNS
have  ||| S:4149 E:4154 ||| VBP
no  ||| S:4154 E:4157 ||| DT
observable  ||| S:4157 E:4176 ||| JJ
phenotype ||| S:4176 E:4185 ||| NN
,  ||| S:4185 E:4187 ||| ,
so  ||| S:4187 E:4190 ||| RB
that  ||| S:4190 E:4195 ||| IN
introduction  ||| S:4195 E:4208 ||| NN
of  ||| S:4208 E:4211 ||| IN
transgenes  ||| S:4211 E:4222 ||| NN
into  ||| S:4222 E:4227 ||| IN
this  ||| S:4227 E:4240 ||| DT
locus  ||| S:4240 E:4246 ||| NN
will  ||| S:4246 E:4251 ||| MD
not  ||| S:4251 E:4255 ||| RB
inherently  ||| S:4255 E:4266 ||| RB
affect  ||| S:4266 E:4273 ||| VB
embryonic  ||| S:4273 E:4283 ||| JJ
development  ||| S:4283 E:4295 ||| NN
[  ||| S:4295 E:4305 ||| -LRB-
14 ||| S:4305 E:4307 ||| CD
,  ||| S:4307 E:4309 ||| ,
15 ||| S:4309 E:4311 ||| CD
] ||| S:4311 E:4312 ||| -RRB-
.  ||| S:4312 E:4314 ||| .
Once  ||| S:4314 E:4319 ||| IN
the  ||| S:4319 E:4323 ||| DT
locus  ||| S:4323 E:4329 ||| NN
is  ||| S:4329 E:4332 ||| VBZ
chosen  ||| S:4332 E:4339 ||| VBN
a  ||| S:4339 E:4341 ||| DT
targeting  ||| S:4341 E:4351 ||| JJ
vector  ||| S:4351 E:4358 ||| NN
is  ||| S:4358 E:4369 ||| VBZ
designed  ||| S:4369 E:4378 ||| VBN
to  ||| S:4378 E:4381 ||| TO
introduce  ||| S:4381 E:4391 ||| VB
a  ||| S:4391 E:4402 ||| DT
pgk ||| S:4402 E:4405 ||| JJ
/ ||| S:4405 E:4406 ||| CD
loxP-Neo  ||| S:4406 E:4415 ||| JJ
cassette  ||| S:4415 E:4424 ||| NN
that  ||| S:4424 E:4429 ||| IN
confers  ||| S:4429 E:4445 ||| JJ
resistance  ||| S:4445 E:4456 ||| NN
to  ||| S:4456 E:4459 ||| TO
G418  ||| S:4459 E:4464 ||| CD
in  ||| S:4464 E:4467 ||| IN
mammalian  ||| S:4467 E:4477 ||| JJ
cells ||| S:4477 E:4482 ||| NNS
.  ||| S:4482 E:4484 ||| .
Importantly ||| S:4484 E:4495 ||| RB
,  ||| S:4495 E:4497 ||| ,
the  ||| S:4497 E:4510 ||| DT
pgk  ||| S:4510 E:4514 ||| JJ
promoter  ||| S:4514 E:4523 ||| NN
of  ||| S:4523 E:4526 ||| IN
this  ||| S:4526 E:4531 ||| DT
cassette  ||| S:4531 E:4540 ||| NN
is  ||| S:4540 E:4551 ||| VBZ
flanked  ||| S:4551 E:4559 ||| VBN
by  ||| S:4559 E:4571 ||| IN
loxP  ||| S:4571 E:4576 ||| JJ
elements  ||| S:4576 E:4585 ||| NNS
so  ||| S:4585 E:4588 ||| RB
that  ||| S:4588 E:4593 ||| IN
the  ||| S:4593 E:4597 ||| DT
promoter  ||| S:4597 E:4614 ||| NN
can  ||| S:4614 E:4618 ||| MD
easily  ||| S:4618 E:4625 ||| RB
be  ||| S:4625 E:4628 ||| VB
removed  ||| S:4628 E:4636 ||| VBN
using  ||| S:4636 E:4642 ||| VBG
Cre  ||| S:4642 E:4646 ||| JJ
recombinase ||| S:4646 E:4657 ||| NN
.  ||| S:4657 E:4659 ||| .
In  ||| S:4659 E:4662 ||| IN
step  ||| S:4662 E:4667 ||| NN
2  ||| S:4667 E:4669 ||| CD
a  ||| S:4669 E:4679 ||| DT
Cre-expression  ||| S:4679 E:4694 ||| JJ
plasmid  ||| S:4694 E:4702 ||| NN
is  ||| S:4702 E:4705 ||| VBZ
transiently  ||| S:4705 E:4717 ||| VBN
introduced  ||| S:4717 E:4728 ||| VBN
into  ||| S:4728 E:4733 ||| IN
the  ||| S:4733 E:4746 ||| DT
pgk ||| S:4746 E:4749 ||| FW
/ ||| S:4749 E:4750 ||| FW
loxP-Neo  ||| S:4750 E:4759 ||| FW
targeted  ||| S:4759 E:4768 ||| FW
ES  ||| S:4768 E:4771 ||| FW
cells ||| S:4771 E:4776 ||| NNS
.  ||| S:4776 E:4786 ||| .
Cre-mediated  ||| S:4786 E:4799 ||| JJ
deletion  ||| S:4799 E:4808 ||| NN
of  ||| S:4808 E:4811 ||| IN
the  ||| S:4811 E:4824 ||| DT
pgk  ||| S:4824 E:4828 ||| JJ
promoter  ||| S:4828 E:4837 ||| NN
results  ||| S:4837 E:4845 ||| NNS
in  ||| S:4845 E:4848 ||| IN
the  ||| S:4848 E:4852 ||| DT
cells  ||| S:4852 E:4866 ||| NNS
reverting  ||| S:4866 E:4876 ||| VBP
to  ||| S:4876 E:4879 ||| TO
G418  ||| S:4879 E:4884 ||| CD
sensitivity  ||| S:4884 E:4896 ||| NN
while  ||| S:4896 E:4902 ||| IN
retaining  ||| S:4902 E:4912 ||| VBG
the  ||| S:4912 E:4925 ||| DT
Neo  ||| S:4925 E:4929 ||| JJ
gene ||| S:4929 E:4933 ||| NN
.  ||| S:4933 E:4935 ||| .
Step  ||| S:4935 E:4940 ||| NN
2  ||| S:4940 E:4942 ||| CD
is  ||| S:4942 E:4945 ||| VBZ
rapid  ||| S:4945 E:4951 ||| JJ
and  ||| S:4951 E:4963 ||| CC
straightforward  ||| S:4963 E:4979 ||| JJ
because  ||| S:4979 E:4987 ||| IN
Cre-mediated  ||| S:4987 E:5000 ||| JJ
recombination  ||| S:5000 E:5014 ||| NN
is  ||| S:5014 E:5025 ||| VBZ
extremely  ||| S:5025 E:5035 ||| RB
efficient ||| S:5035 E:5044 ||| JJ
.  ||| S:5044 E:5046 ||| .
The  ||| S:5046 E:5050 ||| DT
generation  ||| S:5050 E:5061 ||| NN
of  ||| S:5061 E:5064 ||| IN
these  ||| S:5064 E:5070 ||| DT
G418-sensitive  ||| S:5070 E:5093 ||| NNP
ES  ||| S:5093 E:5096 ||| NNP
cells  ||| S:5096 E:5102 ||| NNS
containing  ||| S:5102 E:5122 ||| VBG
Neo  ||| S:5122 E:5126 ||| RB
integrated  ||| S:5126 E:5137 ||| VBN
into  ||| S:5137 E:5142 ||| IN
the  ||| S:5142 E:5155 ||| DT
Hnf3  ||| S:5155 E:5160 ||| CD
α  ||| S:5160 E:5162 ||| CD
locus  ||| S:5162 E:5168 ||| NNS
form  ||| S:5168 E:5173 ||| VBP
the  ||| S:5173 E:5177 ||| DT
basis  ||| S:5177 E:5183 ||| NN
for  ||| S:5183 E:5195 ||| IN
targeting  ||| S:5195 E:5205 ||| VBG
transgenes  ||| S:5205 E:5216 ||| NN
to  ||| S:5216 E:5219 ||| TO
this  ||| S:5219 E:5224 ||| DT
locus ||| S:5224 E:5229 ||| NN
.  ||| S:5229 E:5239 ||| .
In  ||| S:5239 E:5242 ||| IN
step  ||| S:5242 E:5247 ||| NN
3 ||| S:5247 E:5248 ||| CD
,  ||| S:5248 E:5250 ||| ,
a  ||| S:5250 E:5252 ||| DT
general  ||| S:5252 E:5260 ||| JJ
targeting  ||| S:5260 E:5270 ||| JJ
vector  ||| S:5270 E:5277 ||| NN
is  ||| S:5277 E:5280 ||| VBZ
constructed  ||| S:5280 E:5300 ||| VBN
that  ||| S:5300 E:5305 ||| WDT
will  ||| S:5305 E:5310 ||| MD
allow  ||| S:5310 E:5316 ||| VB
the  ||| S:5316 E:5320 ||| DT
introduction  ||| S:5320 E:5333 ||| NN
of  ||| S:5333 E:5336 ||| IN
transgenes  ||| S:5336 E:5347 ||| VBG
to  ||| S:5347 E:5350 ||| TO
the  ||| S:5350 E:5363 ||| DT
Hnf3α ||| S:5363 E:5368 ||| NNP
/ ||| S:5368 E:5369 ||| NNP
Neo  ||| S:5369 E:5373 ||| NNP
locus ||| S:5373 E:5378 ||| NN
.  ||| S:5378 E:5380 ||| .
The  ||| S:5380 E:5384 ||| DT
salient  ||| S:5384 E:5392 ||| JJ
features  ||| S:5392 E:5409 ||| NNS
of  ||| S:5409 E:5412 ||| IN
such  ||| S:5412 E:5417 ||| PDT
a  ||| S:5417 E:5419 ||| DT
vector  ||| S:5419 E:5426 ||| NNS
are  ||| S:5426 E:5430 ||| VBP
shown  ||| S:5430 E:5436 ||| VBN
in  ||| S:5436 E:5439 ||| IN
Fig  ||| S:5439 E:5443 ||| NNP
2 ||| S:5443 E:5444 ||| CD
.  ||| S:5444 E:5446 ||| .
A  ||| S:5446 E:5448 ||| DT
unique  ||| S:5448 E:5464 ||| JJ
SalI  ||| S:5464 E:5469 ||| JJ
restriction  ||| S:5469 E:5481 ||| NN
endonuclease  ||| S:5481 E:5494 ||| NN
site  ||| S:5494 E:5507 ||| NN
allows  ||| S:5507 E:5514 ||| VBZ
the  ||| S:5514 E:5518 ||| DT
introduction  ||| S:5518 E:5531 ||| NN
of  ||| S:5531 E:5534 ||| IN
coding  ||| S:5534 E:5541 ||| JJ
sequences  ||| S:5541 E:5551 ||| NN
into  ||| S:5551 E:5556 ||| IN
this  ||| S:5556 E:5569 ||| DT
vector ||| S:5569 E:5575 ||| NN
.  ||| S:5575 E:5577 ||| .
A  ||| S:5577 E:5579 ||| DT
3 ||| S:5579 E:5580 ||| CD
'  ||| S:5580 E:5582 ||| POS
splice  ||| S:5582 E:5589 ||| JJ
site  ||| S:5589 E:5594 ||| NN
and  ||| S:5594 E:5598 ||| CC
polyadenylation  ||| S:5598 E:5614 ||| JJ
signal  ||| S:5614 E:5621 ||| NN
has  ||| S:5621 E:5633 ||| VBZ
been  ||| S:5633 E:5638 ||| VBN
incorporated  ||| S:5638 E:5651 ||| VBN
to  ||| S:5651 E:5654 ||| TO
facilitate  ||| S:5654 E:5665 ||| VB
proper  ||| S:5665 E:5672 ||| JJ
post-transciptional  ||| S:5672 E:5700 ||| JJ
processing  ||| S:5700 E:5711 ||| NN
of  ||| S:5711 E:5714 ||| IN
transgenes ||| S:5714 E:5724 ||| NN
.  ||| S:5724 E:5726 ||| .
Targeting  ||| S:5726 E:5736 ||| VBG
of  ||| S:5736 E:5739 ||| IN
transgenes  ||| S:5739 E:5750 ||| VBG
to  ||| S:5750 E:5753 ||| TO
the  ||| S:5753 E:5766 ||| DT
Hnf3α ||| S:5766 E:5771 ||| NNP
/ ||| S:5771 E:5772 ||| NNP
Neo  ||| S:5772 E:5776 ||| NNP
locus  ||| S:5776 E:5782 ||| NN
is  ||| S:5782 E:5785 ||| VBZ
mediated  ||| S:5785 E:5794 ||| VBN
by  ||| S:5794 E:5797 ||| IN
two  ||| S:5797 E:5809 ||| CD
arms  ||| S:5809 E:5814 ||| NNS
of  ||| S:5814 E:5817 ||| IN
homology ||| S:5817 E:5825 ||| NN
.  ||| S:5825 E:5827 ||| .
The  ||| S:5827 E:5831 ||| DT
3 ||| S:5831 E:5832 ||| CD
'  ||| S:5832 E:5834 ||| POS
arm  ||| S:5834 E:5838 ||| NN
of  ||| S:5838 E:5841 ||| IN
homology  ||| S:5841 E:5850 ||| NN
contains  ||| S:5850 E:5867 ||| VBZ
nucleotides  ||| S:5867 E:5879 ||| CD
29  ||| S:5879 E:5882 ||| CD
to  ||| S:5882 E:5885 ||| TO
626  ||| S:5885 E:5889 ||| CD
of  ||| S:5889 E:5892 ||| IN
the  ||| S:5892 E:5905 ||| DT
Neo  ||| S:5905 E:5909 ||| JJ
coding  ||| S:5909 E:5916 ||| JJ
sequence  ||| S:5916 E:5925 ||| NN
with  ||| S:5925 E:5930 ||| IN
an  ||| S:5930 E:5941 ||| DT
accompanying  ||| S:5941 E:5963 ||| JJ
pgk  ||| S:5963 E:5967 ||| JJ
promoter  ||| S:5967 E:5976 ||| NN
flanked  ||| S:5976 E:5984 ||| NN
by  ||| S:5984 E:5996 ||| IN
loxP  ||| S:5996 E:6001 ||| JJ
elements ||| S:6001 E:6009 ||| NNS
.  ||| S:6009 E:6011 ||| .
No  ||| S:6011 E:6014 ||| DT
G418  ||| S:6014 E:6019 ||| JJ
resistant  ||| S:6019 E:6037 ||| JJ
colonies  ||| S:6037 E:6046 ||| NNS
were  ||| S:6046 E:6051 ||| VBD
obtained  ||| S:6051 E:6060 ||| VBN
when  ||| S:6060 E:6065 ||| WRB
plasmids  ||| S:6065 E:6074 ||| NNS
containing  ||| S:6074 E:6085 ||| VBG
this  ||| S:6085 E:6098 ||| DT
truncated  ||| S:6098 E:6117 ||| JJ
Neo  ||| S:6117 E:6121 ||| JJ
cassette  ||| S:6121 E:6130 ||| NN
were  ||| S:6130 E:6135 ||| VBD
introduced  ||| S:6135 E:6146 ||| VBN
into  ||| S:6146 E:6159 ||| IN
wild  ||| S:6159 E:6164 ||| JJ
type  ||| S:6164 E:6169 ||| NN
ES  ||| S:6169 E:6172 ||| NN
cells  ||| S:6172 E:6178 ||| NNS
by  ||| S:6178 E:6181 ||| IN
electroporation  ||| S:6181 E:6197 ||| NNS
( ||| S:6197 E:6198 ||| -LRB-
data  ||| S:6198 E:6203 ||| NNS
not  ||| S:6203 E:6207 ||| RB
shown ||| S:6207 E:6212 ||| VBN
) ||| S:6212 E:6213 ||| -RRB-
.  ||| S:6213 E:6223 ||| .
This  ||| S:6223 E:6228 ||| DT
confirmed  ||| S:6228 E:6238 ||| VBN
that  ||| S:6238 E:6243 ||| IN
deletion  ||| S:6243 E:6252 ||| NN
of  ||| S:6252 E:6255 ||| IN
the  ||| S:6255 E:6259 ||| DT
3 ||| S:6259 E:6260 ||| CD
' ||| S:6260 E:6261 ||| POS
-end  ||| S:6261 E:6266 ||| JJ
of  ||| S:6266 E:6278 ||| IN
Neo  ||| S:6278 E:6282 ||| NNP
results  ||| S:6282 E:6290 ||| NNS
in  ||| S:6290 E:6293 ||| IN
loss  ||| S:6293 E:6298 ||| NN
of  ||| S:6298 E:6301 ||| IN
resistance  ||| S:6301 E:6312 ||| NN
to  ||| S:6312 E:6323 ||| TO
G418  ||| S:6323 E:6328 ||| CD
[  ||| S:6328 E:6330 ||| -LRB-
16 ||| S:6330 E:6332 ||| CD
] ||| S:6332 E:6333 ||| -RRB-
.  ||| S:6333 E:6335 ||| .
The  ||| S:6335 E:6339 ||| DT
5 ||| S:6339 E:6340 ||| CD
'  ||| S:6340 E:6342 ||| POS
region  ||| S:6342 E:6349 ||| NN
of  ||| S:6349 E:6352 ||| IN
homology  ||| S:6352 E:6361 ||| JJ
consisted  ||| S:6361 E:6371 ||| NN
of  ||| S:6371 E:6374 ||| IN
4.5  ||| S:6374 E:6378 ||| CD
kb  ||| S:6378 E:6389 ||| NN
of  ||| S:6389 E:6401 ||| IN
Hnf3  ||| S:6401 E:6406 ||| CD
α  ||| S:6406 E:6408 ||| CD
genomic  ||| S:6408 E:6416 ||| JJ
sequence  ||| S:6416 E:6425 ||| NN
that  ||| S:6425 E:6430 ||| WDT
extends  ||| S:6430 E:6446 ||| VBZ
into  ||| S:6446 E:6451 ||| IN
sequences  ||| S:6451 E:6461 ||| NNS
encoding  ||| S:6461 E:6470 ||| VBP
the  ||| S:6470 E:6474 ||| DT
untranslated  ||| S:6474 E:6487 ||| JJ
5 ||| S:6487 E:6488 ||| CD
'  ||| S:6488 E:6490 ||| POS
leader  ||| S:6490 E:6497 ||| NN
region  ||| S:6497 E:6512 ||| NN
of  ||| S:6512 E:6524 ||| IN
Hnf3  ||| S:6524 E:6529 ||| FW
α  ||| S:6529 E:6531 ||| FW
mRNA  ||| S:6531 E:6536 ||| FW
[  ||| S:6536 E:6538 ||| -LRB-
17 ||| S:6538 E:6540 ||| CD
] ||| S:6540 E:6541 ||| -RRB-
.  ||| S:6541 E:6543 ||| .
These  ||| S:6543 E:6549 ||| DT
sequences  ||| S:6549 E:6567 ||| JJ
ensure  ||| S:6567 E:6574 ||| NN
that  ||| S:6574 E:6579 ||| IN
the  ||| S:6579 E:6583 ||| DT
site  ||| S:6583 E:6588 ||| NN
of  ||| S:6588 E:6591 ||| IN
transcriptional  ||| S:6591 E:6607 ||| JJ
initiation  ||| S:6607 E:6618 ||| NN
remains  ||| S:6618 E:6634 ||| VBZ
intact  ||| S:6634 E:6641 ||| JJ
after  ||| S:6641 E:6647 ||| IN
transgenes  ||| S:6647 E:6658 ||| NNS
have  ||| S:6658 E:6663 ||| VBP
been  ||| S:6663 E:6668 ||| VBN
targeted  ||| S:6668 E:6677 ||| VBN
to  ||| S:6677 E:6680 ||| TO
the  ||| S:6680 E:6693 ||| DT
Hnf3  ||| S:6693 E:6698 ||| FW
α  ||| S:6698 E:6700 ||| FW
locus  ||| S:6700 E:6706 ||| FW
[  ||| S:6706 E:6708 ||| -LRB-
17 ||| S:6708 E:6710 ||| CD
] ||| S:6710 E:6711 ||| -RRB-
.  ||| S:6711 E:6721 ||| .
To  ||| S:6721 E:6724 ||| TO
ascertain  ||| S:6724 E:6734 ||| VB
whether  ||| S:6734 E:6742 ||| IN
the  ||| S:6742 E:6746 ||| DT
strategy  ||| S:6746 E:6755 ||| NN
proposed  ||| S:6755 E:6764 ||| VBN
in  ||| S:6764 E:6767 ||| IN
Fig  ||| S:6767 E:6771 ||| NNP
1was  ||| S:6771 E:6784 ||| NNP
feasible  ||| S:6784 E:6793 ||| NN
and  ||| S:6793 E:6797 ||| CC
to  ||| S:6797 E:6800 ||| TO
determine  ||| S:6800 E:6810 ||| VB
the  ||| S:6810 E:6814 ||| DT
efficiency  ||| S:6814 E:6825 ||| NN
of  ||| S:6825 E:6828 ||| IN
such  ||| S:6828 E:6833 ||| PDT
an  ||| S:6833 E:6844 ||| DT
approach  ||| S:6844 E:6853 ||| NN
we  ||| S:6853 E:6856 ||| PRP
attempted  ||| S:6856 E:6866 ||| VBD
to  ||| S:6866 E:6869 ||| TO
introduce  ||| S:6869 E:6879 ||| VB
a  ||| S:6879 E:6890 ||| DT
lacZ  ||| S:6890 E:6895 ||| JJ
transgene  ||| S:6895 E:6905 ||| NN
into  ||| S:6905 E:6910 ||| IN
the  ||| S:6910 E:6923 ||| DT
Hnf3  ||| S:6923 E:6928 ||| FW
α  ||| S:6928 E:6930 ||| FW
locus ||| S:6930 E:6935 ||| FW
.  ||| S:6935 E:6937 ||| .
The  ||| S:6937 E:6941 ||| DT
genotype  ||| S:6941 E:6950 ||| NN
of  ||| S:6950 E:6953 ||| IN
ES  ||| S:6953 E:6956 ||| NNP
cell  ||| S:6956 E:6969 ||| NN
clones  ||| S:6969 E:6976 ||| NNS
from  ||| S:6976 E:6981 ||| IN
each  ||| S:6981 E:6986 ||| DT
step  ||| S:6986 E:6991 ||| NN
of  ||| S:6991 E:6994 ||| IN
the  ||| S:6994 E:6998 ||| DT
procedure  ||| S:6998 E:7008 ||| NN
was  ||| S:7008 E:7012 ||| VBD
determined  ||| S:7012 E:7023 ||| VBN
by  ||| S:7023 E:7034 ||| IN
Southern  ||| S:7034 E:7043 ||| NNP
blot  ||| S:7043 E:7048 ||| JJ
analysis  ||| S:7048 E:7057 ||| NN
of  ||| S:7057 E:7060 ||| IN
genomic  ||| S:7060 E:7068 ||| JJ
DNA  ||| S:7068 E:7072 ||| NN
( ||| S:7072 E:7073 ||| -LRB-
Fig  ||| S:7073 E:7077 ||| NNP
3 ||| S:7077 E:7078 ||| CD
) ||| S:7078 E:7079 ||| -RRB-
.  ||| S:7079 E:7081 ||| .
Figs  ||| S:7081 E:7086 ||| NNP
3aand  ||| S:7086 E:7100 ||| NNP
3bshow  ||| S:7100 E:7107 ||| NNP
that  ||| S:7107 E:7112 ||| IN
the  ||| S:7112 E:7116 ||| DT
genotype  ||| S:7116 E:7125 ||| NN
of  ||| S:7125 E:7128 ||| IN
ES  ||| S:7128 E:7131 ||| NNP
cells  ||| S:7131 E:7137 ||| NNS
at  ||| S:7137 E:7140 ||| IN
each  ||| S:7140 E:7145 ||| DT
stage  ||| S:7145 E:7151 ||| NN
of  ||| S:7151 E:7154 ||| IN
the  ||| S:7154 E:7166 ||| DT
procedure  ||| S:7166 E:7176 ||| NN
could  ||| S:7176 E:7182 ||| MD
be  ||| S:7182 E:7185 ||| VB
distinguished  ||| S:7185 E:7199 ||| VBN
by  ||| S:7199 E:7202 ||| IN
genomic  ||| S:7202 E:7210 ||| JJ
Southern  ||| S:7210 E:7219 ||| JJ
blot  ||| S:7219 E:7232 ||| JJ
analysis  ||| S:7232 E:7241 ||| NN
using  ||| S:7241 E:7247 ||| VBG
a  ||| S:7247 E:7249 ||| DT
single  ||| S:7249 E:7256 ||| JJ
DNA  ||| S:7256 E:7260 ||| NN
probe  ||| S:7260 E:7266 ||| NN
( ||| S:7266 E:7267 ||| -LRB-
probe  ||| S:7267 E:7273 ||| NN
A ||| S:7273 E:7274 ||| NNP
)  ||| S:7274 E:7276 ||| -RRB-
to  ||| S:7276 E:7279 ||| TO
identify  ||| S:7279 E:7288 ||| VB
a  ||| S:7288 E:7299 ||| DT
Hind  ||| S:7299 E:7304 ||| NNP
III ||| S:7304 E:7307 ||| NNP
/ ||| S:7307 E:7308 ||| NNP
EcoRV  ||| S:7308 E:7314 ||| JJ
restriction  ||| S:7314 E:7334 ||| NN
endonuclease  ||| S:7334 E:7347 ||| NN
fragment  ||| S:7347 E:7356 ||| NN
that  ||| S:7356 E:7361 ||| WDT
was  ||| S:7361 E:7365 ||| VBD
specific  ||| S:7365 E:7374 ||| JJ
to  ||| S:7374 E:7377 ||| TO
each  ||| S:7377 E:7382 ||| DT
targeted  ||| S:7382 E:7399 ||| JJ
allele ||| S:7399 E:7405 ||| NN
.  ||| S:7405 E:7407 ||| .
In  ||| S:7407 E:7410 ||| IN
step1  ||| S:7410 E:7416 ||| NNP
we  ||| S:7416 E:7419 ||| PRP
introduced  ||| S:7419 E:7430 ||| VBD
a  ||| S:7430 E:7441 ||| DT
pgkloxP-Neo  ||| S:7441 E:7453 ||| JJ
cassette  ||| S:7453 E:7462 ||| NN
into  ||| S:7462 E:7467 ||| IN
the  ||| S:7467 E:7480 ||| DT
Hnf3  ||| S:7480 E:7485 ||| CD
α  ||| S:7485 E:7487 ||| NNS
locus  ||| S:7487 E:7493 ||| VBP
following  ||| S:7493 E:7503 ||| VBG
the  ||| S:7503 E:7507 ||| DT
procedure  ||| S:7507 E:7525 ||| NN
described  ||| S:7525 E:7535 ||| VBD
in  ||| S:7535 E:7538 ||| IN
materials  ||| S:7538 E:7548 ||| NNS
and  ||| S:7548 E:7552 ||| CC
methods ||| S:7552 E:7559 ||| NNS
.  ||| S:7559 E:7561 ||| .
Fig  ||| S:7561 E:7565 ||| NNP
3bshows  ||| S:7565 E:7573 ||| NNP
that  ||| S:7573 E:7578 ||| WDT
probe  ||| S:7578 E:7592 ||| VBP
A  ||| S:7592 E:7594 ||| DT
identifies  ||| S:7594 E:7605 ||| VBZ
an  ||| S:7605 E:7608 ||| DT
8.0  ||| S:7608 E:7612 ||| FW
kb  ||| S:7612 E:7624 ||| FW
Hind  ||| S:7624 E:7629 ||| NNP
III ||| S:7629 E:7632 ||| NNP
/ ||| S:7632 E:7633 ||| NNP
EcoRV  ||| S:7633 E:7639 ||| JJ
fragment  ||| S:7639 E:7648 ||| NN
in  ||| S:7648 E:7651 ||| IN
wild  ||| S:7651 E:7656 ||| JJ
type  ||| S:7656 E:7669 ||| NN
ES  ||| S:7669 E:7672 ||| NN
cells ||| S:7672 E:7677 ||| NNS
.  ||| S:7677 E:7679 ||| .
Targeting  ||| S:7679 E:7689 ||| VBG
of  ||| S:7689 E:7692 ||| IN
a  ||| S:7692 E:7703 ||| DT
pgkloxP-Neo  ||| S:7703 E:7715 ||| JJ
cassette  ||| S:7715 E:7724 ||| NN
to  ||| S:7724 E:7727 ||| TO
this  ||| S:7727 E:7732 ||| DT
locus  ||| S:7732 E:7746 ||| NN
introduces  ||| S:7746 E:7757 ||| VBZ
a  ||| S:7757 E:7759 ||| DT
unique  ||| S:7759 E:7775 ||| JJ
EcoRV  ||| S:7775 E:7781 ||| JJ
site  ||| S:7781 E:7786 ||| NN
that  ||| S:7786 E:7791 ||| WDT
generates  ||| S:7791 E:7801 ||| VBZ
a  ||| S:7801 E:7803 ||| DT
4.0  ||| S:7803 E:7807 ||| CD
kb  ||| S:7807 E:7819 ||| CD
HindIII ||| S:7819 E:7826 ||| JJ
/ ||| S:7826 E:7827 ||| CD
EcoRV  ||| S:7827 E:7833 ||| JJ
fragment  ||| S:7833 E:7842 ||| NN
also  ||| S:7842 E:7847 ||| RB
detected  ||| S:7847 E:7864 ||| VBN
by  ||| S:7864 E:7867 ||| IN
probe  ||| S:7867 E:7873 ||| NN
A.  ||| S:7873 E:7876 ||| NN
We  ||| S:7876 E:7879 ||| PRP
obtained  ||| S:7879 E:7888 ||| VBD
four  ||| S:7888 E:7893 ||| CD
correctly  ||| S:7893 E:7903 ||| RB
targeted  ||| S:7903 E:7912 ||| VBN
ES  ||| S:7912 E:7915 ||| NNP
cell  ||| S:7915 E:7928 ||| NN
clones  ||| S:7928 E:7935 ||| VBD
out  ||| S:7935 E:7939 ||| RP
of  ||| S:7939 E:7942 ||| IN
200  ||| S:7942 E:7946 ||| CD
that  ||| S:7946 E:7951 ||| WDT
were  ||| S:7951 E:7956 ||| VBD
resistant  ||| S:7956 E:7966 ||| JJ
to  ||| S:7966 E:7969 ||| TO
both  ||| S:7969 E:7974 ||| DT
G418  ||| S:7974 E:7979 ||| NNP
and  ||| S:7979 E:7991 ||| CC
gancyclovir  ||| S:7991 E:8003 ||| NNS
( ||| S:8003 E:8004 ||| -LRB-
Fig  ||| S:8004 E:8008 ||| NNP
3b ||| S:8008 E:8010 ||| NNP
) ||| S:8010 E:8011 ||| -RRB-
.  ||| S:8011 E:8013 ||| .
In  ||| S:8013 E:8016 ||| IN
addition  ||| S:8016 E:8025 ||| NN
to  ||| S:8025 E:8028 ||| TO
the  ||| S:8028 E:8032 ||| DT
data  ||| S:8032 E:8037 ||| NNS
shown  ||| S:8037 E:8043 ||| VBN
in  ||| S:8043 E:8046 ||| IN
Fig  ||| S:8046 E:8058 ||| NNP
3b ||| S:8058 E:8060 ||| NNP
,  ||| S:8060 E:8062 ||| ,
the  ||| S:8062 E:8066 ||| DT
genotype  ||| S:8066 E:8075 ||| NN
of  ||| S:8075 E:8078 ||| IN
these  ||| S:8078 E:8084 ||| DT
colonies  ||| S:8084 E:8093 ||| NN
was  ||| S:8093 E:8097 ||| VBD
confirmed  ||| S:8097 E:8107 ||| VBN
by  ||| S:8107 E:8118 ||| IN
Southern  ||| S:8118 E:8127 ||| NNP
blot  ||| S:8127 E:8132 ||| VBZ
using  ||| S:8132 E:8138 ||| VBG
DNA  ||| S:8138 E:8142 ||| NN
fragments  ||| S:8142 E:8152 ||| NNS
that  ||| S:8152 E:8157 ||| WDT
corresponded  ||| S:8157 E:8170 ||| VBD
to  ||| S:8170 E:8173 ||| TO
3 ||| S:8173 E:8174 ||| CD
'  ||| S:8174 E:8185 ||| POS
Hnf3  ||| S:8185 E:8190 ||| FW
α  ||| S:8190 E:8192 ||| FW
genomic  ||| S:8192 E:8200 ||| FW
sequences  ||| S:8200 E:8210 ||| FW
and  ||| S:8210 E:8214 ||| CC
to  ||| S:8214 E:8226 ||| TO
Neo  ||| S:8226 E:8230 ||| NNP
( ||| S:8230 E:8231 ||| -LRB-
not  ||| S:8231 E:8235 ||| RB
shown ||| S:8235 E:8240 ||| VBN
) ||| S:8240 E:8241 ||| -RRB-
.  ||| S:8241 E:8243 ||| .
These  ||| S:8243 E:8249 ||| DT
correctly  ||| S:8249 E:8267 ||| RB
targeted  ||| S:8267 E:8276 ||| VBN
ES  ||| S:8276 E:8279 ||| NNP
cell  ||| S:8279 E:8284 ||| NN
clones  ||| S:8284 E:8291 ||| NNS
were  ||| S:8291 E:8296 ||| VBD
called  ||| S:8296 E:8303 ||| VBN
Hnf3αloxPNeo  ||| S:8303 E:8316 ||| CD
clones  ||| S:8316 E:8323 ||| CD
1-4  ||| S:8323 E:8335 ||| CD
to  ||| S:8335 E:8338 ||| TO
indicate  ||| S:8338 E:8347 ||| VB
that  ||| S:8347 E:8352 ||| IN
a  ||| S:8352 E:8363 ||| DT
pgkloxP-Neo  ||| S:8363 E:8375 ||| JJ
cassette  ||| S:8375 E:8384 ||| NN
had  ||| S:8384 E:8388 ||| VBD
been  ||| S:8388 E:8401 ||| VBN
introduced  ||| S:8401 E:8412 ||| VBN
into  ||| S:8412 E:8417 ||| IN
the  ||| S:8417 E:8430 ||| DT
Hnf3  ||| S:8430 E:8435 ||| FW
α  ||| S:8435 E:8437 ||| FW
locus ||| S:8437 E:8442 ||| FW
.  ||| S:8442 E:8444 ||| .
Next ||| S:8444 E:8448 ||| JJ
,  ||| S:8448 E:8450 ||| ,
a  ||| S:8450 E:8452 ||| DT
plasmid  ||| S:8452 E:8460 ||| NN
that  ||| S:8460 E:8473 ||| WDT
expresses  ||| S:8473 E:8483 ||| VBZ
Cre-recombinase  ||| S:8483 E:8499 ||| JJ
in  ||| S:8499 E:8502 ||| IN
mammalian  ||| S:8502 E:8512 ||| JJ
cells  ||| S:8512 E:8518 ||| NNS
was  ||| S:8518 E:8522 ||| VBD
introduced  ||| S:8522 E:8541 ||| VBN
into  ||| S:8541 E:8546 ||| IN
Hnf3αloxPNeo  ||| S:8546 E:8559 ||| NNP
ES  ||| S:8559 E:8562 ||| NNP
cells  ||| S:8562 E:8568 ||| NNS
by  ||| S:8568 E:8571 ||| IN
transient  ||| S:8571 E:8581 ||| JJ
transfection  ||| S:8581 E:8602 ||| NNS
( ||| S:8602 E:8603 ||| -LRB-
materials  ||| S:8603 E:8613 ||| NNS
and  ||| S:8613 E:8617 ||| CC
methods ||| S:8617 E:8624 ||| NNS
) ||| S:8624 E:8625 ||| -RRB-
.  ||| S:8625 E:8627 ||| .
The  ||| S:8627 E:8631 ||| DT
expression  ||| S:8631 E:8642 ||| NN
of  ||| S:8642 E:8645 ||| IN
Cre  ||| S:8645 E:8649 ||| NNP
recombinase  ||| S:8649 E:8669 ||| VBD
mediated  ||| S:8669 E:8678 ||| JJ
recombination  ||| S:8678 E:8692 ||| NN
between  ||| S:8692 E:8700 ||| IN
the  ||| S:8700 E:8713 ||| DT
loxP  ||| S:8713 E:8718 ||| JJ
elements  ||| S:8718 E:8727 ||| NNS
that  ||| S:8727 E:8732 ||| WDT
flanked  ||| S:8732 E:8740 ||| VBZ
the  ||| S:8740 E:8753 ||| DT
pgk  ||| S:8753 E:8757 ||| JJ
promoter ||| S:8757 E:8765 ||| NN
.  ||| S:8765 E:8767 ||| .
Southern  ||| S:8767 E:8776 ||| JJ
blot  ||| S:8776 E:8781 ||| JJ
analysis  ||| S:8781 E:8798 ||| NN
( ||| S:8798 E:8799 ||| -LRB-
fig  ||| S:8799 E:8803 ||| CD
3 ||| S:8803 E:8804 ||| CD
)  ||| S:8804 E:8806 ||| -RRB-
shows  ||| S:8806 E:8812 ||| VBZ
that  ||| S:8812 E:8817 ||| DT
deletion  ||| S:8817 E:8826 ||| NN
of  ||| S:8826 E:8829 ||| IN
the  ||| S:8829 E:8842 ||| DT
pgk  ||| S:8842 E:8846 ||| JJ
promoter  ||| S:8846 E:8855 ||| NN
in  ||| S:8855 E:8858 ||| IN
Hnf3αloxPNeo  ||| S:8858 E:8871 ||| CD
cells  ||| S:8871 E:8885 ||| NNS
generated  ||| S:8885 E:8895 ||| VBD
a  ||| S:8895 E:8897 ||| DT
predicted  ||| S:8897 E:8907 ||| VBD
3.5  ||| S:8907 E:8911 ||| CD
kb  ||| S:8911 E:8923 ||| CD
HindIII ||| S:8923 E:8930 ||| JJ
/ ||| S:8930 E:8931 ||| CD
EcoRV  ||| S:8931 E:8937 ||| JJ
fragment  ||| S:8937 E:8946 ||| NN
that  ||| S:8946 E:8951 ||| WDT
was  ||| S:8951 E:8963 ||| VBD
detected  ||| S:8963 E:8972 ||| VBN
by  ||| S:8972 E:8975 ||| IN
probe  ||| S:8975 E:8981 ||| NN
A.  ||| S:8981 E:8984 ||| NN
Moreover ||| S:8984 E:8992 ||| RB
,  ||| S:8992 E:8994 ||| ,
Fig  ||| S:8994 E:8998 ||| NNP
3cshows  ||| S:8998 E:9006 ||| NNP
that  ||| S:9006 E:9011 ||| IN
deletion  ||| S:9011 E:9020 ||| NN
of  ||| S:9020 E:9031 ||| IN
the  ||| S:9031 E:9044 ||| DT
pgk  ||| S:9044 E:9048 ||| JJ
promoter  ||| S:9048 E:9057 ||| NN
resulted  ||| S:9057 E:9066 ||| VBD
in  ||| S:9066 E:9069 ||| IN
the  ||| S:9069 E:9081 ||| DT
Hnf3αloxPNeo  ||| S:9081 E:9094 ||| CD
cells  ||| S:9094 E:9100 ||| NNS
reverting  ||| S:9100 E:9110 ||| VBP
to  ||| S:9110 E:9113 ||| TO
G418-sensitivity  ||| S:9113 E:9130 ||| CD
because  ||| S:9130 E:9146 ||| IN
the  ||| S:9146 E:9150 ||| DT
promoter  ||| S:9150 E:9159 ||| NN
is  ||| S:9159 E:9162 ||| VBZ
necessary  ||| S:9162 E:9172 ||| JJ
for  ||| S:9172 E:9185 ||| IN
Neo  ||| S:9185 E:9189 ||| NNP
expression ||| S:9189 E:9199 ||| NN
.  ||| S:9199 E:9201 ||| .
The  ||| S:9201 E:9214 ||| DT
pgk  ||| S:9214 E:9218 ||| JJ
promoter  ||| S:9218 E:9227 ||| NN
was  ||| S:9227 E:9231 ||| VBD
deleted  ||| S:9231 E:9239 ||| VBN
from  ||| S:9239 E:9244 ||| IN
25 ||| S:9244 E:9246 ||| CD
%  ||| S:9246 E:9248 ||| NN
of  ||| S:9248 E:9259 ||| IN
transfected  ||| S:9259 E:9271 ||| JJ
Hnf3αloxPNeo  ||| S:9271 E:9284 ||| NNP
ES  ||| S:9284 E:9287 ||| NNP
cells ||| S:9287 E:9292 ||| NNS
,  ||| S:9292 E:9294 ||| ,
using  ||| S:9294 E:9300 ||| VBG
the  ||| S:9300 E:9304 ||| DT
approach  ||| S:9304 E:9321 ||| NN
described  ||| S:9321 E:9331 ||| VBD
in  ||| S:9331 E:9334 ||| IN
materials  ||| S:9334 E:9344 ||| NNS
and  ||| S:9344 E:9348 ||| CC
methods ||| S:9348 E:9355 ||| NNS
.  ||| S:9355 E:9357 ||| .
ES  ||| S:9357 E:9360 ||| NNP
cell  ||| S:9360 E:9365 ||| NN
lines  ||| S:9365 E:9371 ||| NNS
from  ||| S:9371 E:9384 ||| IN
which  ||| S:9384 E:9390 ||| WDT
the  ||| S:9390 E:9403 ||| DT
pgk  ||| S:9403 E:9407 ||| JJ
promoter  ||| S:9407 E:9416 ||| NN
had  ||| S:9416 E:9420 ||| VBD
been  ||| S:9420 E:9425 ||| VBN
deleted  ||| S:9425 E:9433 ||| NNS
were  ||| S:9433 E:9446 ||| VBD
named  ||| S:9446 E:9452 ||| VBN
Hnf3αΔpgk-Neo  ||| S:9452 E:9466 ||| CD
to  ||| S:9466 E:9469 ||| TO
indicate  ||| S:9469 E:9478 ||| VB
this  ||| S:9478 E:9483 ||| DT
event ||| S:9483 E:9488 ||| NN
.  ||| S:9488 E:9498 ||| .
Our  ||| S:9498 E:9502 ||| PRP$
ultimate  ||| S:9502 E:9511 ||| JJ
goal  ||| S:9511 E:9516 ||| NN
is  ||| S:9516 E:9519 ||| VBZ
to  ||| S:9519 E:9522 ||| TO
target  ||| S:9522 E:9529 ||| VB
a  ||| S:9529 E:9531 ||| DT
number  ||| S:9531 E:9538 ||| NN
of  ||| S:9538 E:9541 ||| IN
different  ||| S:9541 E:9559 ||| JJ
transgenes  ||| S:9559 E:9570 ||| NN
to  ||| S:9570 E:9573 ||| TO
the  ||| S:9573 E:9586 ||| DT
Hnf3  ||| S:9586 E:9591 ||| JJ
α  ||| S:9591 E:9593 ||| JJ
locus  ||| S:9593 E:9599 ||| NN
with  ||| S:9599 E:9604 ||| IN
the  ||| S:9604 E:9608 ||| DT
aim  ||| S:9608 E:9612 ||| NN
of  ||| S:9612 E:9623 ||| IN
expressing  ||| S:9623 E:9634 ||| VBG
them  ||| S:9634 E:9639 ||| PRP
ectopically  ||| S:9639 E:9651 ||| VBD
throughout  ||| S:9651 E:9662 ||| IN
the  ||| S:9662 E:9666 ||| DT
embryonic  ||| S:9666 E:9676 ||| JJ
gut  ||| S:9676 E:9688 ||| NN
endoderm ||| S:9688 E:9696 ||| NN
.  ||| S:9696 E:9698 ||| .
To  ||| S:9698 E:9701 ||| TO
facilitate  ||| S:9701 E:9712 ||| VB
this  ||| S:9712 E:9717 ||| DT
we  ||| S:9717 E:9720 ||| PRP
have  ||| S:9720 E:9725 ||| VBP
designed  ||| S:9725 E:9734 ||| VBN
a  ||| S:9734 E:9736 ||| DT
general  ||| S:9736 E:9752 ||| JJ
targeting  ||| S:9752 E:9762 ||| JJ
vector  ||| S:9762 E:9769 ||| NN
that  ||| S:9769 E:9774 ||| WDT
can  ||| S:9774 E:9778 ||| MD
accommodate  ||| S:9778 E:9790 ||| VB
and  ||| S:9790 E:9794 ||| CC
allow  ||| S:9794 E:9800 ||| VB
expression  ||| S:9800 E:9819 ||| NN
of  ||| S:9819 E:9822 ||| IN
any  ||| S:9822 E:9826 ||| DT
open  ||| S:9826 E:9831 ||| JJ
reading  ||| S:9831 E:9839 ||| NN
frame  ||| S:9839 E:9845 ||| NN
when  ||| S:9845 E:9850 ||| WRB
targeted  ||| S:9850 E:9859 ||| VBN
to  ||| S:9859 E:9862 ||| TO
the  ||| S:9862 E:9875 ||| DT
Hnf3  ||| S:9875 E:9880 ||| JJ
α  ||| S:9880 E:9882 ||| JJ
locus  ||| S:9882 E:9888 ||| NN
in  ||| S:9888 E:9891 ||| IN
Hnf3αΔpgk-Neo  ||| S:9891 E:9905 ||| NNP
ES  ||| S:9905 E:9916 ||| NNP
cells ||| S:9916 E:9921 ||| NNS
.  ||| S:9921 E:9923 ||| .
There  ||| S:9923 E:9929 ||| EX
are  ||| S:9929 E:9933 ||| VBP
a  ||| S:9933 E:9935 ||| DT
number  ||| S:9935 E:9942 ||| NN
of  ||| S:9942 E:9945 ||| IN
important  ||| S:9945 E:9955 ||| JJ
features  ||| S:9955 E:9964 ||| NNS
associated  ||| S:9964 E:9983 ||| VBN
with  ||| S:9983 E:9988 ||| IN
this  ||| S:9988 E:9993 ||| DT
vector  ||| S:9993 E:10000 ||| NN
that  ||| S:10000 E:10005 ||| WDT
are  ||| S:10005 E:10009 ||| VBP
illustrated  ||| S:10009 E:10021 ||| VBN
in  ||| S:10021 E:10024 ||| IN
Fig  ||| S:10024 E:10028 ||| NNP
2 ||| S:10028 E:10029 ||| CD
.  ||| S:10029 E:10031 ||| .
This  ||| S:10031 E:10044 ||| DT
plasmid  ||| S:10044 E:10052 ||| NN
includes  ||| S:10052 E:10061 ||| VBZ
a  ||| S:10061 E:10063 ||| DT
unique  ||| S:10063 E:10079 ||| JJ
SalI  ||| S:10079 E:10084 ||| JJ
restriction  ||| S:10084 E:10096 ||| NN
endonuclease  ||| S:10096 E:10117 ||| NN
cut-site  ||| S:10117 E:10126 ||| NN
for  ||| S:10126 E:10130 ||| IN
insertion  ||| S:10130 E:10140 ||| NN
of  ||| S:10140 E:10143 ||| IN
open  ||| S:10143 E:10148 ||| JJ
reading  ||| S:10148 E:10156 ||| NN
frames ||| S:10156 E:10162 ||| NNS
,  ||| S:10162 E:10164 ||| ,
followed  ||| S:10164 E:10173 ||| VBN
by  ||| S:10173 E:10184 ||| IN
intron  ||| S:10184 E:10191 ||| NN
and  ||| S:10191 E:10195 ||| CC
poly-  ||| S:10195 E:10201 ||| NNP
[ ||| S:10201 E:10202 ||| -LRB-
A ||| S:10202 E:10203 ||| NNP
]  ||| S:10203 E:10205 ||| -RRB-
addition  ||| S:10205 E:10214 ||| NN
sequences  ||| S:10214 E:10224 ||| NN
for  ||| S:10224 E:10228 ||| IN
correct  ||| S:10228 E:10244 ||| JJ
post-transcriptional  ||| S:10244 E:10265 ||| JJ
processing  ||| S:10265 E:10276 ||| NN
of  ||| S:10276 E:10279 ||| IN
transgenic  ||| S:10279 E:10290 ||| JJ
RNA ||| S:10290 E:10293 ||| NNP
.  ||| S:10293 E:10295 ||| .
The  ||| S:10295 E:10299 ||| DT
5 ||| S:10299 E:10300 ||| CD
'  ||| S:10300 E:10310 ||| POS
arm  ||| S:10310 E:10314 ||| NN
of  ||| S:10314 E:10317 ||| IN
homology  ||| S:10317 E:10326 ||| NN
within  ||| S:10326 E:10333 ||| IN
the  ||| S:10333 E:10337 ||| DT
targeting  ||| S:10337 E:10347 ||| JJ
vector  ||| S:10347 E:10354 ||| NN
defines  ||| S:10354 E:10362 ||| VBZ
where  ||| S:10362 E:10376 ||| WRB
the  ||| S:10376 E:10380 ||| DT
transgene  ||| S:10380 E:10390 ||| NN
is  ||| S:10390 E:10393 ||| VBZ
positioned  ||| S:10393 E:10404 ||| VBN
relative  ||| S:10404 E:10413 ||| JJ
to  ||| S:10413 E:10416 ||| TO
the  ||| S:10416 E:10429 ||| DT
Hnf3  ||| S:10429 E:10434 ||| FW
α  ||| S:10434 E:10436 ||| FW
locus ||| S:10436 E:10441 ||| FW
.  ||| S:10441 E:10443 ||| .
We  ||| S:10443 E:10446 ||| PRP
maintained  ||| S:10446 E:10457 ||| VBD
the  ||| S:10457 E:10469 ||| DT
integrity  ||| S:10469 E:10479 ||| NN
of  ||| S:10479 E:10482 ||| IN
the  ||| S:10482 E:10486 ||| DT
endogenous  ||| S:10486 E:10506 ||| FW
Hnf3  ||| S:10506 E:10511 ||| FW
α  ||| S:10511 E:10513 ||| FW
transcriptional  ||| S:10513 E:10529 ||| FW
start-site  ||| S:10529 E:10540 ||| FW
to  ||| S:10540 E:10551 ||| TO
ensure  ||| S:10551 E:10558 ||| VB
bona-fide  ||| S:10558 E:10568 ||| JJ
expression  ||| S:10568 E:10579 ||| NN
of  ||| S:10579 E:10582 ||| IN
any  ||| S:10582 E:10586 ||| DT
inserted  ||| S:10586 E:10595 ||| JJ
transgene ||| S:10595 E:10604 ||| NN
.  ||| S:10604 E:10606 ||| .
This  ||| S:10606 E:10619 ||| DT
was  ||| S:10619 E:10623 ||| VBD
achieved  ||| S:10623 E:10632 ||| VBN
by  ||| S:10632 E:10635 ||| IN
using  ||| S:10635 E:10641 ||| VBG
a  ||| S:10641 E:10643 ||| DT
5 ||| S:10643 E:10644 ||| CD
'  ||| S:10644 E:10646 ||| POS
arm  ||| S:10646 E:10650 ||| NN
of  ||| S:10650 E:10653 ||| IN
homology  ||| S:10653 E:10662 ||| NNS
whose  ||| S:10662 E:10668 ||| WP$
3 ||| S:10668 E:10669 ||| CD
'  ||| S:10669 E:10671 ||| POS
end  ||| S:10671 E:10675 ||| NN
lay  ||| S:10675 E:10687 ||| VBD
within  ||| S:10687 E:10694 ||| IN
genomic  ||| S:10694 E:10702 ||| JJ
sequences  ||| S:10702 E:10712 ||| NNS
encoding  ||| S:10712 E:10721 ||| VBP
the  ||| S:10721 E:10725 ||| DT
untranslated  ||| S:10725 E:10738 ||| JJ
leader  ||| S:10738 E:10753 ||| NN
of  ||| S:10753 E:10756 ||| IN
the  ||| S:10756 E:10769 ||| DT
Hnf3  ||| S:10769 E:10774 ||| FW
α  ||| S:10774 E:10776 ||| FW
mRNA  ||| S:10776 E:10781 ||| FW
( ||| S:10781 E:10782 ||| -LRB-
Fig  ||| S:10782 E:10786 ||| NNP
2 ||| S:10786 E:10787 ||| CD
)  ||| S:10787 E:10789 ||| -RRB-
[  ||| S:10789 E:10791 ||| -LRB-
17 ||| S:10791 E:10793 ||| CD
] ||| S:10793 E:10794 ||| -RRB-
.  ||| S:10794 E:10796 ||| .
The  ||| S:10796 E:10800 ||| DT
3 ||| S:10800 E:10801 ||| CD
'  ||| S:10801 E:10803 ||| POS
arm  ||| S:10803 E:10815 ||| NN
of  ||| S:10815 E:10818 ||| IN
homology  ||| S:10818 E:10827 ||| JJ
consisted  ||| S:10827 E:10837 ||| NN
of  ||| S:10837 E:10840 ||| IN
the  ||| S:10840 E:10844 ||| DT
5 ||| S:10844 E:10845 ||| CD
'  ||| S:10845 E:10847 ||| POS
end  ||| S:10847 E:10851 ||| NN
of  ||| S:10851 E:10863 ||| IN
Neo  ||| S:10863 E:10867 ||| NNP
coding  ||| S:10867 E:10874 ||| NNS
sequence  ||| S:10874 E:10883 ||| VBP
accompanied  ||| S:10883 E:10895 ||| VBN
by  ||| S:10895 E:10906 ||| IN
the  ||| S:10906 E:10919 ||| DT
pgk  ||| S:10919 E:10923 ||| JJ
promoter  ||| S:10923 E:10932 ||| NN
with  ||| S:10932 E:10937 ||| IN
flanking  ||| S:10937 E:10955 ||| JJ
loxP  ||| S:10955 E:10960 ||| JJ
elements ||| S:10960 E:10968 ||| NNS
.  ||| S:10968 E:10970 ||| .
This  ||| S:10970 E:10984 ||| DT
Neo  ||| S:10984 E:10988 ||| JJ
fragment  ||| S:10988 E:10997 ||| NN
lacked  ||| S:10997 E:11004 ||| VBD
sequences  ||| S:11004 E:11022 ||| VBN
encoding  ||| S:11022 E:11031 ||| VBG
the  ||| S:11031 E:11035 ||| DT
last  ||| S:11035 E:11040 ||| JJ
49  ||| S:11040 E:11043 ||| CD
amino  ||| S:11043 E:11049 ||| CD
acids  ||| S:11049 E:11055 ||| NNS
of  ||| S:11055 E:11058 ||| IN
neomycin  ||| S:11058 E:11075 ||| JJ
phosphotransferase ||| S:11075 E:11093 ||| NN
.  ||| S:11093 E:11095 ||| .
Such  ||| S:11095 E:11100 ||| JJ
truncation  ||| S:11100 E:11111 ||| NN
of  ||| S:11111 E:11114 ||| IN
the  ||| S:11114 E:11127 ||| DT
Neo  ||| S:11127 E:11131 ||| JJ
gene  ||| S:11131 E:11136 ||| NN
disrupted  ||| S:11136 E:11146 ||| VBD
its  ||| S:11146 E:11150 ||| PRP$
ability  ||| S:11150 E:11158 ||| NN
to  ||| S:11158 E:11169 ||| TO
encode  ||| S:11169 E:11176 ||| VB
resistance  ||| S:11176 E:11187 ||| NN
to  ||| S:11187 E:11190 ||| TO
G418  ||| S:11190 E:11195 ||| CD
confirming  ||| S:11195 E:11206 ||| VBG
the  ||| S:11206 E:11210 ||| DT
results  ||| S:11210 E:11218 ||| NNS
of  ||| S:11218 E:11221 ||| IN
Beck  ||| S:11221 E:11235 ||| NNP
et  ||| S:11235 E:11238 ||| FW
al  ||| S:11238 E:11241 ||| FW
( ||| S:11241 E:11242 ||| -LRB-
data  ||| S:11242 E:11247 ||| NNS
not  ||| S:11247 E:11251 ||| RB
shown ||| S:11251 E:11256 ||| VBN
)  ||| S:11256 E:11258 ||| -RRB-
[  ||| S:11258 E:11260 ||| -LRB-
16 ||| S:11260 E:11262 ||| CD
] ||| S:11262 E:11263 ||| -RRB-
.  ||| S:11263 E:11273 ||| .
Therefore ||| S:11273 E:11282 ||| RB
,  ||| S:11282 E:11284 ||| ,
ES  ||| S:11284 E:11287 ||| NNP
cells  ||| S:11287 E:11293 ||| NNS
that  ||| S:11293 E:11298 ||| WDT
randomly  ||| S:11298 E:11307 ||| RB
integrate  ||| S:11307 E:11317 ||| VB
this  ||| S:11317 E:11322 ||| DT
targeting  ||| S:11322 E:11340 ||| JJ
vector  ||| S:11340 E:11347 ||| NN
would  ||| S:11347 E:11353 ||| MD
remain  ||| S:11353 E:11360 ||| VB
sensitive  ||| S:11360 E:11370 ||| JJ
to  ||| S:11370 E:11373 ||| TO
G418 ||| S:11373 E:11377 ||| CD
.  ||| S:11377 E:11379 ||| .
In  ||| S:11379 E:11382 ||| IN
contrast ||| S:11382 E:11390 ||| NN
,  ||| S:11390 E:11392 ||| ,
we  ||| S:11392 E:11403 ||| PRP
predicted  ||| S:11403 E:11413 ||| VBD
that  ||| S:11413 E:11418 ||| DT
homologous  ||| S:11418 E:11429 ||| JJ
recombination  ||| S:11429 E:11443 ||| NN
between  ||| S:11443 E:11451 ||| IN
the  ||| S:11451 E:11463 ||| DT
truncated  ||| S:11463 E:11482 ||| JJ
Neo  ||| S:11482 E:11486 ||| JJ
sequences  ||| S:11486 E:11496 ||| NN
in  ||| S:11496 E:11499 ||| IN
the  ||| S:11499 E:11503 ||| DT
targeting  ||| S:11503 E:11513 ||| JJ
vector  ||| S:11513 E:11528 ||| NN
and  ||| S:11528 E:11541 ||| CC
Neo  ||| S:11541 E:11545 ||| NNP
sequences  ||| S:11545 E:11555 ||| NN
within  ||| S:11555 E:11562 ||| IN
Hnf3αΔpgk-Neo  ||| S:11562 E:11576 ||| NNP
ES  ||| S:11576 E:11587 ||| NNP
cells  ||| S:11587 E:11593 ||| NNS
would  ||| S:11593 E:11599 ||| MD
reconstitute  ||| S:11599 E:11612 ||| VB
expression  ||| S:11612 E:11623 ||| NN
of  ||| S:11623 E:11626 ||| IN
active  ||| S:11626 E:11633 ||| JJ
neomycin  ||| S:11633 E:11650 ||| JJ
phosphotransferase  ||| S:11650 E:11669 ||| NN
and  ||| S:11669 E:11673 ||| CC
so  ||| S:11673 E:11676 ||| RB
confer  ||| S:11676 E:11683 ||| JJ
resistance  ||| S:11683 E:11694 ||| NN
to  ||| S:11694 E:11697 ||| TO
G418 ||| S:11697 E:11701 ||| CD
.  ||| S:11701 E:11703 ||| .
This  ||| S:11703 E:11716 ||| DT
in  ||| S:11716 E:11719 ||| IN
turn  ||| S:11719 E:11724 ||| NN
implies  ||| S:11724 E:11732 ||| VBZ
that ||| S:11732 E:11736 ||| IN
,  ||| S:11736 E:11738 ||| ,
following  ||| S:11738 E:11748 ||| VBG
electroporation  ||| S:11748 E:11764 ||| NN
of  ||| S:11764 E:11767 ||| IN
this  ||| S:11767 E:11780 ||| DT
targeting  ||| S:11780 E:11790 ||| JJ
vector  ||| S:11790 E:11797 ||| NN
into  ||| S:11797 E:11802 ||| IN
Hnf3αΔpgk-Neo  ||| S:11802 E:11816 ||| NNP
ES  ||| S:11816 E:11819 ||| NNP
cells ||| S:11819 E:11824 ||| NNS
,  ||| S:11824 E:11826 ||| ,
100 ||| S:11826 E:11829 ||| CD
%  ||| S:11829 E:11831 ||| NN
of  ||| S:11831 E:11834 ||| IN
G418  ||| S:11834 E:11847 ||| CD
resistant  ||| S:11847 E:11857 ||| JJ
colonies  ||| S:11857 E:11866 ||| NNS
would  ||| S:11866 E:11872 ||| MD
have  ||| S:11872 E:11877 ||| VB
undergone  ||| S:11877 E:11887 ||| VBN
homologous  ||| S:11887 E:11906 ||| JJ
recombination ||| S:11906 E:11919 ||| NN
.  ||| S:11919 E:11921 ||| .
To  ||| S:11921 E:11924 ||| TO
test  ||| S:11924 E:11929 ||| VB
this  ||| S:11929 E:11934 ||| DT
prediction  ||| S:11934 E:11945 ||| NN
we  ||| S:11945 E:11948 ||| PRP
generated  ||| S:11948 E:11958 ||| VBD
a  ||| S:11958 E:11968 ||| DT
targeting  ||| S:11968 E:11978 ||| JJ
vector  ||| S:11978 E:11985 ||| NN
that  ||| S:11985 E:11990 ||| WDT
contained  ||| S:11990 E:12000 ||| VBD
the  ||| S:12000 E:12013 ||| DT
LacZ  ||| S:12013 E:12018 ||| JJ
gene  ||| S:12018 E:12023 ||| NN
from  ||| S:12023 E:12037 ||| IN
E.coli ||| S:12037 E:12043 ||| CD
.  ||| S:12043 E:12045 ||| .
Homologous  ||| S:12045 E:12056 ||| JJ
recombination  ||| S:12056 E:12078 ||| NN
should  ||| S:12078 E:12085 ||| MD
place  ||| S:12085 E:12091 ||| VB
expression  ||| S:12091 E:12102 ||| NN
of  ||| S:12102 E:12105 ||| IN
this  ||| S:12105 E:12110 ||| DT
transgene  ||| S:12110 E:12120 ||| NN
under  ||| S:12120 E:12126 ||| IN
the  ||| S:12126 E:12130 ||| DT
control  ||| S:12130 E:12146 ||| NN
of  ||| S:12146 E:12158 ||| IN
Hnf3  ||| S:12158 E:12163 ||| CD
α  ||| S:12163 E:12165 ||| NNS
transcriptional  ||| S:12165 E:12181 ||| VBP
regulatory  ||| S:12181 E:12200 ||| JJ
elements ||| S:12200 E:12208 ||| NNS
.  ||| S:12208 E:12210 ||| .
This  ||| S:12210 E:12215 ||| DT
plasmid  ||| S:12215 E:12223 ||| NN
was  ||| S:12223 E:12227 ||| VBD
introduced  ||| S:12227 E:12238 ||| VBN
into  ||| S:12238 E:12243 ||| IN
Hnf3αΔpgk-Neo  ||| S:12243 E:12257 ||| NNP
ES  ||| S:12257 E:12268 ||| NNP
cells  ||| S:12268 E:12274 ||| NNS
by  ||| S:12274 E:12277 ||| IN
electroporation  ||| S:12277 E:12293 ||| NN
and  ||| S:12293 E:12297 ||| CC
fifteen  ||| S:12297 E:12305 ||| JJ
colonies  ||| S:12305 E:12314 ||| NNS
were  ||| S:12314 E:12327 ||| VBD
collected  ||| S:12327 E:12337 ||| VBN
that  ||| S:12337 E:12342 ||| WDT
were  ||| S:12342 E:12347 ||| VBD
resistant  ||| S:12347 E:12357 ||| JJ
to  ||| S:12357 E:12360 ||| TO
G418 ||| S:12360 E:12364 ||| CD
.  ||| S:12364 E:12366 ||| .
The  ||| S:12366 E:12370 ||| DT
genotype  ||| S:12370 E:12379 ||| NN
of  ||| S:12379 E:12382 ||| IN
the  ||| S:12382 E:12394 ||| DT
colonies  ||| S:12394 E:12403 ||| NN
was  ||| S:12403 E:12407 ||| VBD
again  ||| S:12407 E:12413 ||| RB
ascertained  ||| S:12413 E:12425 ||| VBN
by  ||| S:12425 E:12428 ||| IN
Southern  ||| S:12428 E:12437 ||| NNP
blot  ||| S:12437 E:12442 ||| JJ
analysis  ||| S:12442 E:12451 ||| NN
of  ||| S:12451 E:12462 ||| IN
genomic  ||| S:12462 E:12470 ||| JJ
DNA ||| S:12470 E:12473 ||| NN
.  ||| S:12473 E:12475 ||| .
Fig  ||| S:12475 E:12479 ||| NNP
3α  ||| S:12479 E:12482 ||| NNP
shows  ||| S:12482 E:12488 ||| VBZ
that  ||| S:12488 E:12493 ||| DT
introduction  ||| S:12493 E:12506 ||| NN
of  ||| S:12506 E:12509 ||| IN
the  ||| S:12509 E:12522 ||| DT
LacZ  ||| S:12522 E:12527 ||| JJ
transgene  ||| S:12527 E:12537 ||| NN
into  ||| S:12537 E:12542 ||| IN
the  ||| S:12542 E:12555 ||| DT
Hnf3  ||| S:12555 E:12560 ||| CD
α  ||| S:12560 E:12562 ||| CD
locus  ||| S:12562 E:12568 ||| NNS
was  ||| S:12568 E:12572 ||| VBD
predicted  ||| S:12572 E:12582 ||| VBN
to  ||| S:12582 E:12593 ||| TO
generate  ||| S:12593 E:12602 ||| VB
a  ||| S:12602 E:12604 ||| DT
2.7  ||| S:12604 E:12608 ||| CD
kb  ||| S:12608 E:12620 ||| CD
HindIII  ||| S:12620 E:12628 ||| JJ
/  ||| S:12628 E:12639 ||| CD
EcoRV  ||| S:12639 E:12645 ||| JJ
fragment  ||| S:12645 E:12654 ||| NN
that  ||| S:12654 E:12659 ||| IN
interacts  ||| S:12659 E:12669 ||| NN
with  ||| S:12669 E:12682 ||| IN
probe  ||| S:12682 E:12688 ||| NN
A.  ||| S:12688 E:12691 ||| NNP
Fig  ||| S:12691 E:12695 ||| NNP
4shows  ||| S:12695 E:12702 ||| NNP
that  ||| S:12702 E:12707 ||| IN
fifteen  ||| S:12707 E:12715 ||| VBG
out  ||| S:12715 E:12719 ||| RP
of  ||| S:12719 E:12722 ||| IN
fifteen  ||| S:12722 E:12730 ||| JJ
ES  ||| S:12730 E:12733 ||| NNP
cell  ||| S:12733 E:12746 ||| NN
lines  ||| S:12746 E:12752 ||| NNS
that  ||| S:12752 E:12757 ||| WDT
were  ||| S:12757 E:12762 ||| VBD
resistant  ||| S:12762 E:12772 ||| JJ
to  ||| S:12772 E:12775 ||| TO
G418  ||| S:12775 E:12780 ||| NNP
had  ||| S:12780 E:12784 ||| VBD
undergone  ||| S:12784 E:12794 ||| VBN
homologous  ||| S:12794 E:12813 ||| JJ
recombination  ||| S:12813 E:12827 ||| NN
and  ||| S:12827 E:12831 ||| CC
contained  ||| S:12831 E:12841 ||| VBD
the  ||| S:12841 E:12854 ||| DT
LacZ  ||| S:12854 E:12859 ||| JJ
transgene  ||| S:12859 E:12869 ||| NNS
correctly  ||| S:12869 E:12879 ||| RB
targeted  ||| S:12879 E:12888 ||| VBN
to  ||| S:12888 E:12899 ||| TO
the  ||| S:12899 E:12912 ||| DT
Hnf3  ||| S:12912 E:12917 ||| FW
α  ||| S:12917 E:12919 ||| FW
locus ||| S:12919 E:12924 ||| FW
.  ||| S:12924 E:12926 ||| .
These  ||| S:12926 E:12932 ||| DT
data  ||| S:12932 E:12937 ||| NNS
confirm  ||| S:12937 E:12945 ||| VBP
the  ||| S:12945 E:12957 ||| DT
extraordinary  ||| S:12957 E:12971 ||| JJ
efficiency  ||| S:12971 E:12982 ||| NN
of  ||| S:12982 E:12985 ||| IN
using  ||| S:12985 E:12991 ||| VBG
this  ||| S:12991 E:12996 ||| DT
approach  ||| S:12996 E:13005 ||| NN
to  ||| S:13005 E:13008 ||| TO
target  ||| S:13008 E:13023 ||| VB
transgenes  ||| S:13023 E:13034 ||| VBN
to  ||| S:13034 E:13037 ||| TO
a  ||| S:13037 E:13039 ||| DT
marked  ||| S:13039 E:13046 ||| JJ
genomic  ||| S:13046 E:13054 ||| JJ
locus ||| S:13054 E:13059 ||| NN
.  ||| S:13059 E:13069 ||| .
We  ||| S:13069 E:13072 ||| PRP
predicted  ||| S:13072 E:13082 ||| VBD
that  ||| S:13082 E:13087 ||| DT
transgenes  ||| S:13087 E:13098 ||| NN
inserted  ||| S:13098 E:13107 ||| VBN
into  ||| S:13107 E:13112 ||| IN
the  ||| S:13112 E:13125 ||| DT
Hnf3  ||| S:13125 E:13130 ||| CD
α  ||| S:13130 E:13132 ||| CD
locus  ||| S:13132 E:13138 ||| NNS
would  ||| S:13138 E:13144 ||| MD
be  ||| S:13144 E:13147 ||| VB
expressed  ||| S:13147 E:13165 ||| VBN
throughout  ||| S:13165 E:13176 ||| IN
the  ||| S:13176 E:13180 ||| DT
endoderm  ||| S:13180 E:13189 ||| NN
of  ||| S:13189 E:13192 ||| IN
the  ||| S:13192 E:13196 ||| DT
developing  ||| S:13196 E:13207 ||| VBG
gut ||| S:13207 E:13210 ||| NN
.  ||| S:13210 E:13212 ||| .
To  ||| S:13212 E:13215 ||| TO
determine  ||| S:13215 E:13233 ||| VB
if  ||| S:13233 E:13236 ||| IN
this  ||| S:13236 E:13241 ||| DT
was  ||| S:13241 E:13245 ||| VBD
true  ||| S:13245 E:13250 ||| JJ
we  ||| S:13250 E:13253 ||| PRP
generated  ||| S:13253 E:13263 ||| VBD
embryos  ||| S:13263 E:13271 ||| VBN
from  ||| S:13271 E:13276 ||| IN
ES  ||| S:13276 E:13279 ||| NNP
cells  ||| S:13279 E:13293 ||| NNS
containing  ||| S:13293 E:13304 ||| VBG
LacZ  ||| S:13304 E:13309 ||| JJ
at  ||| S:13309 E:13312 ||| IN
the  ||| S:13312 E:13325 ||| DT
Hnf3  ||| S:13325 E:13330 ||| FW
α  ||| S:13330 E:13332 ||| FW
locus  ||| S:13332 E:13338 ||| FW
(  ||| S:13338 E:13349 ||| -LRB-
Hnf3αLacZ  ||| S:13349 E:13359 ||| NNP
ES  ||| S:13359 E:13362 ||| NNP
cells ||| S:13362 E:13367 ||| NNS
)  ||| S:13367 E:13369 ||| -RRB-
and  ||| S:13369 E:13373 ||| CC
stained  ||| S:13373 E:13381 ||| NN
for  ||| S:13381 E:13393 ||| IN
expression  ||| S:13393 E:13404 ||| NN
of  ||| S:13404 E:13407 ||| IN
β-galactosidase ||| S:13407 E:13422 ||| JJ
.  ||| S:13422 E:13424 ||| .
Mouse  ||| S:13424 E:13430 ||| NNP
embryos  ||| S:13430 E:13438 ||| VBD
derived  ||| S:13438 E:13446 ||| VBN
solely  ||| S:13446 E:13461 ||| RB
from  ||| S:13461 E:13466 ||| IN
ES  ||| S:13466 E:13469 ||| NNP
cells  ||| S:13469 E:13475 ||| NNS
were  ||| S:13475 E:13480 ||| VBD
generated  ||| S:13480 E:13490 ||| VBN
by  ||| S:13490 E:13493 ||| IN
tetraploid  ||| S:13493 E:13504 ||| JJ
aggregation  ||| S:13504 E:13516 ||| NN
as  ||| S:13516 E:13527 ||| IN
described  ||| S:13527 E:13537 ||| VBN
previously  ||| S:13537 E:13548 ||| RB
[  ||| S:13548 E:13550 ||| -LRB-
18 ||| S:13550 E:13552 ||| CD
,  ||| S:13552 E:13554 ||| ,
19 ||| S:13554 E:13556 ||| CD
,  ||| S:13556 E:13558 ||| ,
20 ||| S:13558 E:13560 ||| CD
] ||| S:13560 E:13561 ||| -RRB-
.  ||| S:13561 E:13563 ||| .
A  ||| S:13563 E:13565 ||| DT
total  ||| S:13565 E:13571 ||| NN
of  ||| S:13571 E:13574 ||| IN
10  ||| S:13574 E:13577 ||| CD
embryos  ||| S:13577 E:13593 ||| NNS
were  ||| S:13593 E:13598 ||| VBD
produced  ||| S:13598 E:13607 ||| VBN
and  ||| S:13607 E:13611 ||| CC
all  ||| S:13611 E:13615 ||| RB
showed  ||| S:13615 E:13622 ||| VBD
the  ||| S:13622 E:13626 ||| DT
same  ||| S:13626 E:13631 ||| JJ
pattern  ||| S:13631 E:13639 ||| NN
of  ||| S:13639 E:13650 ||| IN
β-galactosidase  ||| S:13650 E:13666 ||| JJ
expression ||| S:13666 E:13676 ||| NN
.  ||| S:13676 E:13678 ||| .
Fig  ||| S:13678 E:13682 ||| NNP
4bshows  ||| S:13682 E:13690 ||| NNP
β-galactosidase  ||| S:13690 E:13714 ||| JJ
staining  ||| S:13714 E:13723 ||| NN
in  ||| S:13723 E:13735 ||| IN
Hnf3αLacZ  ||| S:13735 E:13745 ||| CD
embryos  ||| S:13745 E:13753 ||| NN
at  ||| S:13753 E:13756 ||| IN
10.5  ||| S:13756 E:13761 ||| CD
days  ||| S:13761 E:13766 ||| NNS
of  ||| S:13766 E:13777 ||| IN
embryonic  ||| S:13777 E:13787 ||| JJ
development ||| S:13787 E:13798 ||| NN
.  ||| S:13798 E:13800 ||| .
As  ||| S:13800 E:13803 ||| RB
expected ||| S:13803 E:13811 ||| VBN
,  ||| S:13811 E:13813 ||| ,
β-galactosidase  ||| S:13813 E:13829 ||| NNP
was  ||| S:13829 E:13841 ||| VBD
expressed  ||| S:13841 E:13851 ||| VBN
throughout  ||| S:13851 E:13862 ||| IN
the  ||| S:13862 E:13866 ||| DT
gut ||| S:13866 E:13869 ||| NN
,  ||| S:13869 E:13871 ||| ,
liver  ||| S:13871 E:13877 ||| NN
and  ||| S:13877 E:13881 ||| CC
at  ||| S:13881 E:13884 ||| IN
particularly  ||| S:13884 E:13905 ||| RB
high  ||| S:13905 E:13910 ||| JJ
levels  ||| S:13910 E:13917 ||| NNS
in  ||| S:13917 E:13920 ||| IN
the  ||| S:13920 E:13924 ||| DT
developing  ||| S:13924 E:13935 ||| VBG
stomach ||| S:13935 E:13942 ||| NN
.  ||| S:13942 E:13944 ||| .
Endogenous  ||| S:13944 E:13955 ||| NNP
Hnf3α  ||| S:13955 E:13961 ||| NNP
is  ||| S:13961 E:13972 ||| VBZ
also  ||| S:13972 E:13977 ||| RB
expressed  ||| S:13977 E:13987 ||| VBN
in  ||| S:13987 E:13990 ||| IN
the  ||| S:13990 E:13994 ||| DT
floorplate  ||| S:13994 E:14005 ||| NN
of  ||| S:14005 E:14008 ||| IN
the  ||| S:14008 E:14012 ||| DT
neural  ||| S:14012 E:14019 ||| JJ
tube  ||| S:14019 E:14024 ||| NN
as  ||| S:14024 E:14027 ||| IN
well  ||| S:14027 E:14040 ||| RB
as  ||| S:14040 E:14043 ||| IN
the  ||| S:14043 E:14047 ||| DT
notochord ||| S:14047 E:14056 ||| NN
.  ||| S:14056 E:14058 ||| .
However ||| S:14058 E:14065 ||| RB
,  ||| S:14065 E:14067 ||| ,
expression  ||| S:14067 E:14078 ||| NN
of  ||| S:14078 E:14081 ||| IN
β-galactosidase  ||| S:14081 E:14097 ||| JJ
in  ||| S:14097 E:14117 ||| IN
Hnf3αLacZ  ||| S:14117 E:14127 ||| CD
transgenic  ||| S:14127 E:14138 ||| CD
embryos  ||| S:14138 E:14146 ||| NNS
was  ||| S:14146 E:14158 ||| VBD
undetectable  ||| S:14158 E:14171 ||| VBN
in  ||| S:14171 E:14174 ||| IN
these  ||| S:14174 E:14180 ||| DT
tissues ||| S:14180 E:14187 ||| NNS
.  ||| S:14187 E:14189 ||| .
In  ||| S:14189 E:14192 ||| IN
generating  ||| S:14192 E:14203 ||| VBG
the  ||| S:14203 E:14216 ||| DT
Hnf3αLacZ  ||| S:14216 E:14226 ||| NN
targeting  ||| S:14226 E:14236 ||| VBG
vector  ||| S:14236 E:14243 ||| NN
we  ||| S:14243 E:14246 ||| PRP
deleted  ||| S:14246 E:14262 ||| VBD
all  ||| S:14262 E:14266 ||| DT
genomic  ||| S:14266 E:14274 ||| JJ
sequences  ||| S:14274 E:14284 ||| NNS
lying  ||| S:14284 E:14290 ||| VBG
3 ||| S:14290 E:14291 ||| CD
'  ||| S:14291 E:14293 ||| ''
to  ||| S:14293 E:14296 ||| TO
the  ||| S:14296 E:14300 ||| DT
first  ||| S:14300 E:14306 ||| JJ
intron  ||| S:14306 E:14313 ||| NN
of  ||| S:14313 E:14316 ||| IN
the  ||| S:14316 E:14329 ||| DT
Hnf3  ||| S:14329 E:14334 ||| JJ
α  ||| S:14334 E:14336 ||| JJ
gene ||| S:14336 E:14340 ||| NN
.  ||| S:14340 E:14342 ||| .
It  ||| S:14342 E:14345 ||| PRP
is  ||| S:14345 E:14348 ||| VBZ
likely  ||| S:14348 E:14355 ||| RB
that  ||| S:14355 E:14360 ||| IN
this  ||| S:14360 E:14373 ||| DT
intron  ||| S:14373 E:14380 ||| NN
or  ||| S:14380 E:14383 ||| CC
other  ||| S:14383 E:14389 ||| JJ
untranslated  ||| S:14389 E:14402 ||| JJ
sequences  ||| S:14402 E:14412 ||| NNS
contain  ||| S:14412 E:14420 ||| VBP
regulatory  ||| S:14420 E:14439 ||| JJ
elements  ||| S:14439 E:14448 ||| NNS
that  ||| S:14448 E:14453 ||| WDT
specifically  ||| S:14453 E:14466 ||| RB
direct  ||| S:14466 E:14473 ||| JJ
expression  ||| S:14473 E:14484 ||| NN
of  ||| S:14484 E:14496 ||| IN
Hnf3αLacZ  ||| S:14496 E:14506 ||| CD
in  ||| S:14506 E:14509 ||| IN
the  ||| S:14509 E:14513 ||| DT
floorplate  ||| S:14513 E:14524 ||| NN
of  ||| S:14524 E:14527 ||| IN
the  ||| S:14527 E:14539 ||| DT
neural  ||| S:14539 E:14546 ||| JJ
tube  ||| S:14546 E:14551 ||| NN
and  ||| S:14551 E:14555 ||| CC
notochord  ||| S:14555 E:14565 ||| NNS
[  ||| S:14565 E:14567 ||| -LRB-
21 ||| S:14567 E:14569 ||| CD
] ||| S:14569 E:14570 ||| -RRB-
.  ||| S:14570 E:14572 ||| .
Indeed  ||| S:14572 E:14579 ||| RB
when  ||| S:14579 E:14593 ||| WRB
LacZ  ||| S:14593 E:14598 ||| NNP
is  ||| S:14598 E:14601 ||| VBZ
introduced  ||| S:14601 E:14612 ||| VBN
into  ||| S:14612 E:14617 ||| IN
exon  ||| S:14617 E:14622 ||| CD
2  ||| S:14622 E:14624 ||| CD
in  ||| S:14624 E:14627 ||| IN
ES  ||| S:14627 E:14638 ||| NNP
cells ||| S:14638 E:14643 ||| NNS
,  ||| S:14643 E:14645 ||| ,
leaving  ||| S:14645 E:14653 ||| VBG
the  ||| S:14653 E:14657 ||| DT
first  ||| S:14657 E:14663 ||| JJ
intron  ||| S:14663 E:14670 ||| JJ
intact ||| S:14670 E:14676 ||| JJ
,  ||| S:14676 E:14678 ||| ,
expression  ||| S:14678 E:14689 ||| NN
of  ||| S:14689 E:14700 ||| IN
β-galactosidase  ||| S:14700 E:14716 ||| NNP
is  ||| S:14716 E:14719 ||| VBZ
readily  ||| S:14719 E:14727 ||| RB
detectable  ||| S:14727 E:14738 ||| VBN
in  ||| S:14738 E:14741 ||| IN
the  ||| S:14741 E:14745 ||| DT
neural-tube  ||| S:14745 E:14765 ||| JJ
floorplate  ||| S:14765 E:14776 ||| NN
and  ||| S:14776 E:14780 ||| CC
notochord  ||| S:14780 E:14790 ||| NNS
[  ||| S:14790 E:14792 ||| -LRB-
9 ||| S:14792 E:14793 ||| CD
] ||| S:14793 E:14794 ||| -RRB-
.  ||| S:14794 E:14818 ||| .
Discussion  ||| S:14818 E:14829 ||| NN
and  ||| S:14829 E:14833 ||| CC
conclusions  ||| S:14833 E:14853 ||| NNS
We  ||| S:14853 E:14856 ||| PRP
have  ||| S:14856 E:14861 ||| VBP
described  ||| S:14861 E:14871 ||| VBN
a  ||| S:14871 E:14873 ||| DT
method  ||| S:14873 E:14880 ||| NN
that  ||| S:14880 E:14885 ||| WDT
allows  ||| S:14885 E:14892 ||| VBZ
transgenes  ||| S:14892 E:14903 ||| VBN
to  ||| S:14903 E:14906 ||| TO
be  ||| S:14906 E:14917 ||| VB
easily  ||| S:14917 E:14924 ||| RB
targeted  ||| S:14924 E:14933 ||| VBN
to  ||| S:14933 E:14936 ||| TO
a  ||| S:14936 E:14938 ||| DT
defined  ||| S:14938 E:14946 ||| JJ
locus  ||| S:14946 E:14952 ||| NN
in  ||| S:14952 E:14955 ||| IN
the  ||| S:14955 E:14959 ||| DT
mouse  ||| S:14959 E:14965 ||| NN
genome  ||| S:14965 E:14972 ||| NN
in  ||| S:14972 E:14983 ||| IN
ES  ||| S:14983 E:14986 ||| NNP
cells ||| S:14986 E:14991 ||| NNS
.  ||| S:14991 E:14993 ||| .
Although  ||| S:14993 E:15002 ||| IN
this  ||| S:15002 E:15007 ||| DT
is  ||| S:15007 E:15010 ||| VBZ
a  ||| S:15010 E:15012 ||| DT
multiple-step  ||| S:15012 E:15026 ||| JJ
procedure ||| S:15026 E:15035 ||| NN
,  ||| S:15035 E:15037 ||| ,
once  ||| S:15037 E:15050 ||| RB
the  ||| S:15050 E:15054 ||| DT
chosen  ||| S:15054 E:15061 ||| JJ
locus  ||| S:15061 E:15067 ||| NN
has  ||| S:15067 E:15071 ||| VBZ
been  ||| S:15071 E:15076 ||| VBN
targeted  ||| S:15076 E:15085 ||| VBN
using  ||| S:15085 E:15091 ||| VBG
homologous  ||| S:15091 E:15110 ||| JJ
recombination ||| S:15110 E:15123 ||| NN
,  ||| S:15123 E:15125 ||| ,
subsequent  ||| S:15125 E:15136 ||| JJ
manipulations  ||| S:15136 E:15150 ||| NNS
are  ||| S:15150 E:15154 ||| VBP
extremely  ||| S:15154 E:15172 ||| RB
efficient ||| S:15172 E:15181 ||| JJ
.  ||| S:15181 E:15183 ||| .
Indeed  ||| S:15183 E:15190 ||| RB
in  ||| S:15190 E:15193 ||| IN
the  ||| S:15193 E:15197 ||| DT
final  ||| S:15197 E:15203 ||| JJ
step ||| S:15203 E:15207 ||| NN
,  ||| S:15207 E:15209 ||| ,
where  ||| S:15209 E:15215 ||| WRB
the  ||| S:15215 E:15219 ||| DT
transgene  ||| S:15219 E:15229 ||| NN
of  ||| S:15229 E:15240 ||| IN
interest  ||| S:15240 E:15249 ||| NN
is  ||| S:15249 E:15252 ||| VBZ
targeted  ||| S:15252 E:15261 ||| VBN
to  ||| S:15261 E:15264 ||| TO
the  ||| S:15264 E:15268 ||| DT
desired  ||| S:15268 E:15276 ||| JJ
locus ||| S:15276 E:15281 ||| NN
,  ||| S:15281 E:15283 ||| ,
we  ||| S:15283 E:15286 ||| PRP
found  ||| S:15286 E:15292 ||| VBD
that  ||| S:15292 E:15305 ||| IN
100 ||| S:15305 E:15308 ||| CD
%  ||| S:15308 E:15310 ||| NN
of  ||| S:15310 E:15313 ||| IN
G418  ||| S:15313 E:15318 ||| CD
resistant  ||| S:15318 E:15328 ||| JJ
ES  ||| S:15328 E:15331 ||| NNP
cell  ||| S:15331 E:15336 ||| NN
colonies  ||| S:15336 E:15345 ||| NNS
were  ||| S:15345 E:15350 ||| VBD
correctly  ||| S:15350 E:15368 ||| RB
targeted ||| S:15368 E:15376 ||| VBN
.  ||| S:15376 E:15378 ||| .
Transgenic  ||| S:15378 E:15389 ||| NNP
mice  ||| S:15389 E:15394 ||| NNS
and  ||| S:15394 E:15398 ||| CC
embryos  ||| S:15398 E:15406 ||| NNS
can  ||| S:15406 E:15410 ||| MD
be  ||| S:15410 E:15413 ||| VB
generated  ||| S:15413 E:15423 ||| VBN
from  ||| S:15423 E:15436 ||| IN
these  ||| S:15436 E:15442 ||| DT
ES  ||| S:15442 E:15445 ||| NNP
cells  ||| S:15445 E:15451 ||| NNS
by  ||| S:15451 E:15454 ||| IN
standard  ||| S:15454 E:15463 ||| JJ
injection  ||| S:15463 E:15473 ||| NN
into  ||| S:15473 E:15478 ||| IN
blastocysts  ||| S:15478 E:15490 ||| NN
and  ||| S:15490 E:15502 ||| CC
subsequent  ||| S:15502 E:15513 ||| JJ
breeding  ||| S:15513 E:15522 ||| NN
of  ||| S:15522 E:15525 ||| IN
the  ||| S:15525 E:15529 ||| DT
resulting  ||| S:15529 E:15539 ||| VBG
chimeric  ||| S:15539 E:15548 ||| JJ
mice ||| S:15548 E:15552 ||| NNS
.  ||| S:15552 E:15554 ||| .
It  ||| S:15554 E:15557 ||| PRP
is  ||| S:15557 E:15568 ||| VBZ
worth  ||| S:15568 E:15574 ||| JJ
noting ||| S:15574 E:15580 ||| NN
,  ||| S:15580 E:15582 ||| ,
however ||| S:15582 E:15589 ||| RB
,  ||| S:15589 E:15591 ||| ,
that  ||| S:15591 E:15596 ||| WDT
if  ||| S:15596 E:15599 ||| IN
germline  ||| S:15599 E:15608 ||| JJ
transmission  ||| S:15608 E:15621 ||| NN
is  ||| S:15621 E:15624 ||| VBZ
the  ||| S:15624 E:15636 ||| DT
aim  ||| S:15636 E:15640 ||| NN
of  ||| S:15640 E:15643 ||| IN
the  ||| S:15643 E:15647 ||| DT
experiment  ||| S:15647 E:15658 ||| NN
it  ||| S:15658 E:15661 ||| PRP
is  ||| S:15661 E:15664 ||| VBZ
important  ||| S:15664 E:15674 ||| JJ
to  ||| S:15674 E:15677 ||| TO
ensure  ||| S:15677 E:15684 ||| VB
that  ||| S:15684 E:15689 ||| IN
the  ||| S:15689 E:15701 ||| DT
"Δpgk-Neo ||| S:15701 E:15710 ||| NN
"  ||| S:15710 E:15712 ||| ''
cells  ||| S:15712 E:15718 ||| NNS
generated  ||| S:15718 E:15728 ||| VBN
in  ||| S:15728 E:15731 ||| IN
step  ||| S:15731 E:15736 ||| NN
2  ||| S:15736 E:15738 ||| CD
are  ||| S:15738 E:15742 ||| VBP
germline  ||| S:15742 E:15759 ||| JJ
competent ||| S:15759 E:15768 ||| NN
.  ||| S:15768 E:15770 ||| .
This  ||| S:15770 E:15775 ||| DT
is  ||| S:15775 E:15778 ||| VBZ
important  ||| S:15778 E:15788 ||| JJ
because  ||| S:15788 E:15796 ||| IN
each  ||| S:15796 E:15801 ||| DT
round  ||| S:15801 E:15807 ||| NN
of  ||| S:15807 E:15810 ||| IN
clonal  ||| S:15810 E:15825 ||| JJ
selection  ||| S:15825 E:15835 ||| NN
increases  ||| S:15835 E:15845 ||| VBZ
the  ||| S:15845 E:15849 ||| DT
likelihood  ||| S:15849 E:15860 ||| NN
of  ||| S:15860 E:15863 ||| IN
losing  ||| S:15863 E:15870 ||| VBG
germline  ||| S:15870 E:15887 ||| JJ
competency  ||| S:15887 E:15898 ||| NN
of  ||| S:15898 E:15901 ||| IN
the  ||| S:15901 E:15905 ||| DT
ES  ||| S:15905 E:15908 ||| NNP
cells ||| S:15908 E:15913 ||| NNS
.  ||| S:15913 E:15923 ||| .
The  ||| S:15923 E:15927 ||| DT
targeting  ||| S:15927 E:15937 ||| VBG
of  ||| S:15937 E:15940 ||| IN
transgenes  ||| S:15940 E:15951 ||| NN
into  ||| S:15951 E:15956 ||| IN
a  ||| S:15956 E:15958 ||| DT
given  ||| S:15958 E:15964 ||| VBN
locus  ||| S:15964 E:15970 ||| NN
has  ||| S:15970 E:15974 ||| VBZ
a  ||| S:15974 E:15984 ||| DT
number  ||| S:15984 E:15991 ||| NN
of  ||| S:15991 E:15994 ||| IN
advantages  ||| S:15994 E:16005 ||| NNS
over  ||| S:16005 E:16010 ||| IN
traditional  ||| S:16010 E:16022 ||| JJ
methods  ||| S:16022 E:16030 ||| NNS
of  ||| S:16030 E:16033 ||| IN
generating  ||| S:16033 E:16052 ||| VBG
transgenic  ||| S:16052 E:16063 ||| JJ
mice ||| S:16063 E:16067 ||| NNS
.  ||| S:16067 E:16069 ||| .
Traditionally ||| S:16069 E:16082 ||| RB
,  ||| S:16082 E:16084 ||| ,
transgenic  ||| S:16084 E:16095 ||| JJ
mice  ||| S:16095 E:16100 ||| NNS
are  ||| S:16100 E:16112 ||| VBP
produced  ||| S:16112 E:16121 ||| VBN
by  ||| S:16121 E:16124 ||| IN
injection  ||| S:16124 E:16134 ||| NN
of  ||| S:16134 E:16137 ||| IN
DNA  ||| S:16137 E:16141 ||| NN
into  ||| S:16141 E:16146 ||| IN
the  ||| S:16146 E:16150 ||| DT
male  ||| S:16150 E:16155 ||| JJ
pronucleus  ||| S:16155 E:16166 ||| NN
of  ||| S:16166 E:16177 ||| IN
fertilized  ||| S:16177 E:16188 ||| JJ
mouse  ||| S:16188 E:16194 ||| NN
eggs ||| S:16194 E:16198 ||| NNS
.  ||| S:16198 E:16200 ||| .
A  ||| S:16200 E:16202 ||| DT
variable  ||| S:16202 E:16211 ||| JJ
number  ||| S:16211 E:16218 ||| NN
of  ||| S:16218 E:16221 ||| IN
copies  ||| S:16221 E:16228 ||| NNS
of  ||| S:16228 E:16231 ||| IN
the  ||| S:16231 E:16243 ||| DT
transgene  ||| S:16243 E:16253 ||| NNS
are  ||| S:16253 E:16257 ||| VBP
then  ||| S:16257 E:16262 ||| RB
integrated  ||| S:16262 E:16273 ||| VBN
into  ||| S:16273 E:16278 ||| IN
the  ||| S:16278 E:16282 ||| DT
mouse  ||| S:16282 E:16288 ||| NN
genome  ||| S:16288 E:16295 ||| NN
at  ||| S:16295 E:16306 ||| IN
random  ||| S:16306 E:16313 ||| JJ
locations ||| S:16313 E:16322 ||| NNS
.  ||| S:16322 E:16324 ||| .
The  ||| S:16324 E:16328 ||| DT
position  ||| S:16328 E:16337 ||| NN
and  ||| S:16337 E:16341 ||| CC
number  ||| S:16341 E:16348 ||| NN
of  ||| S:16348 E:16351 ||| IN
transgene  ||| S:16351 E:16369 ||| JJ
copies  ||| S:16369 E:16376 ||| NNS
can  ||| S:16376 E:16380 ||| MD
have  ||| S:16380 E:16385 ||| VB
a  ||| S:16385 E:16387 ||| DT
profound  ||| S:16387 E:16396 ||| JJ
effect  ||| S:16396 E:16403 ||| NN
on  ||| S:16403 E:16406 ||| IN
their  ||| S:16406 E:16412 ||| PRP$
expression ||| S:16412 E:16422 ||| NN
.  ||| S:16422 E:16424 ||| .
In  ||| S:16424 E:16435 ||| IN
some  ||| S:16435 E:16440 ||| DT
cases  ||| S:16440 E:16446 ||| NNS
expression  ||| S:16446 E:16457 ||| NN
is  ||| S:16457 E:16460 ||| VBZ
repressed  ||| S:16460 E:16470 ||| JJ
or ||| S:16470 E:16472 ||| CC
,  ||| S:16472 E:16474 ||| ,
in  ||| S:16474 E:16477 ||| IN
contrast ||| S:16477 E:16485 ||| NN
,  ||| S:16485 E:16495 ||| ,
undesirably  ||| S:16495 E:16507 ||| VBD
activated  ||| S:16507 E:16517 ||| VBN
at  ||| S:16517 E:16520 ||| IN
ectopic  ||| S:16520 E:16528 ||| JJ
sites ||| S:16528 E:16533 ||| NNS
.  ||| S:16533 E:16535 ||| .
When  ||| S:16535 E:16540 ||| WRB
transgenes  ||| S:16540 E:16551 ||| NNS
are  ||| S:16551 E:16563 ||| VBP
targeted  ||| S:16563 E:16572 ||| VBN
to  ||| S:16572 E:16575 ||| TO
a  ||| S:16575 E:16577 ||| DT
known  ||| S:16577 E:16583 ||| JJ
genomic  ||| S:16583 E:16591 ||| NNS
locus  ||| S:16591 E:16597 ||| VBP
such  ||| S:16597 E:16602 ||| JJ
variation  ||| S:16602 E:16612 ||| NN
is  ||| S:16612 E:16615 ||| VBZ
avoided  ||| S:16615 E:16631 ||| VBN
and  ||| S:16631 E:16635 ||| CC
expression  ||| S:16635 E:16646 ||| NN
of  ||| S:16646 E:16649 ||| IN
the  ||| S:16649 E:16653 ||| DT
transgene  ||| S:16653 E:16663 ||| NN
is  ||| S:16663 E:16666 ||| VBZ
significantly  ||| S:16666 E:16680 ||| RB
more  ||| S:16680 E:16693 ||| RBR
predictable  ||| S:16693 E:16705 ||| JJ
[  ||| S:16705 E:16707 ||| -LRB-
7 ||| S:16707 E:16708 ||| CD
] ||| S:16708 E:16709 ||| -RRB-
.  ||| S:16709 E:16711 ||| .
Such  ||| S:16711 E:16716 ||| JJ
control  ||| S:16716 E:16724 ||| NN
over  ||| S:16724 E:16729 ||| IN
the  ||| S:16729 E:16733 ||| DT
site  ||| S:16733 E:16738 ||| NN
and  ||| S:16738 E:16742 ||| CC
level  ||| S:16742 E:16748 ||| NN
of  ||| S:16748 E:16759 ||| IN
expression  ||| S:16759 E:16770 ||| NN
is  ||| S:16770 E:16773 ||| VBZ
important  ||| S:16773 E:16783 ||| JJ
because  ||| S:16783 E:16791 ||| IN
variations  ||| S:16791 E:16802 ||| NNS
could  ||| S:16802 E:16808 ||| MD
have  ||| S:16808 E:16821 ||| VB
unpredictable  ||| S:16821 E:16835 ||| JJ
impacts  ||| S:16835 E:16843 ||| NNS
on  ||| S:16843 E:16846 ||| IN
the  ||| S:16846 E:16850 ||| DT
phenotype  ||| S:16850 E:16860 ||| NN
presented  ||| S:16860 E:16870 ||| VBN
by  ||| S:16870 E:16873 ||| IN
the  ||| S:16873 E:16885 ||| DT
transgenic  ||| S:16885 E:16896 ||| JJ
mice ||| S:16896 E:16900 ||| NNS
.  ||| S:16900 E:16910 ||| .
Introduction  ||| S:16910 E:16923 ||| NN
of  ||| S:16923 E:16926 ||| IN
single  ||| S:16926 E:16933 ||| JJ
copy  ||| S:16933 E:16938 ||| NN
transgenes  ||| S:16938 E:16949 ||| NN
into  ||| S:16949 E:16954 ||| IN
the  ||| S:16954 E:16967 ||| DT
hydroxyphosphoribosyl  ||| S:16967 E:16997 ||| JJ
transferase  ||| S:16997 E:17009 ||| NNS
( ||| S:17009 E:17010 ||| -LRB-
HPRT ||| S:17010 E:17014 ||| NNP
)  ||| S:17014 E:17016 ||| -RRB-
locus  ||| S:17016 E:17022 ||| NN
has  ||| S:17022 E:17026 ||| VBZ
been  ||| S:17026 E:17031 ||| VBN
previously  ||| S:17031 E:17042 ||| RB
described  ||| S:17042 E:17060 ||| VBN
by  ||| S:17060 E:17063 ||| IN
Bronson  ||| S:17063 E:17080 ||| NNP
et  ||| S:17080 E:17083 ||| FW
al  ||| S:17083 E:17086 ||| FW
.  ||| S:17086 E:17088 ||| .
This  ||| S:17088 E:17093 ||| DT
approach  ||| S:17093 E:17102 ||| NN
successfully  ||| S:17102 E:17123 ||| RB
overcomes  ||| S:17123 E:17133 ||| VBZ
the  ||| S:17133 E:17137 ||| DT
problems  ||| S:17137 E:17146 ||| NNS
associated  ||| S:17146 E:17157 ||| VBN
with  ||| S:17157 E:17162 ||| IN
the  ||| S:17162 E:17166 ||| DT
integration  ||| S:17166 E:17178 ||| NN
of  ||| S:17178 E:17189 ||| IN
variable  ||| S:17189 E:17198 ||| JJ
copy  ||| S:17198 E:17203 ||| NN
numbers  ||| S:17203 E:17211 ||| NNS
of  ||| S:17211 E:17214 ||| IN
transgenes  ||| S:17214 E:17225 ||| NN
into  ||| S:17225 E:17230 ||| IN
random  ||| S:17230 E:17237 ||| JJ
genomic  ||| S:17237 E:17253 ||| JJ
locations ||| S:17253 E:17262 ||| NNS
.  ||| S:17262 E:17264 ||| .
However ||| S:17264 E:17271 ||| RB
,  ||| S:17271 E:17273 ||| ,
it  ||| S:17273 E:17276 ||| PRP
is  ||| S:17276 E:17279 ||| VBZ
only  ||| S:17279 E:17284 ||| RB
suitable  ||| S:17284 E:17293 ||| JJ
for  ||| S:17293 E:17297 ||| IN
introduction  ||| S:17297 E:17310 ||| NN
of  ||| S:17310 E:17321 ||| IN
transgenes  ||| S:17321 E:17332 ||| VBG
to  ||| S:17332 E:17335 ||| TO
the  ||| S:17335 E:17339 ||| DT
HPRT  ||| S:17339 E:17344 ||| NNP
locus  ||| S:17344 E:17350 ||| NN
and ||| S:17350 E:17353 ||| CC
,  ||| S:17353 E:17355 ||| ,
in  ||| S:17355 E:17358 ||| IN
addition ||| S:17358 E:17366 ||| NN
,  ||| S:17366 E:17368 ||| ,
requires  ||| S:17368 E:17377 ||| VBZ
the  ||| S:17377 E:17389 ||| DT
availability  ||| S:17389 E:17402 ||| NN
of  ||| S:17402 E:17405 ||| IN
HPRT-negative  ||| S:17405 E:17419 ||| NNP
ES  ||| S:17419 E:17422 ||| NNP
cell  ||| S:17422 E:17427 ||| NN
lines ||| S:17427 E:17432 ||| NNS
.  ||| S:17432 E:17434 ||| .
Cre-mediated  ||| S:17434 E:17455 ||| JJ
targeting  ||| S:17455 E:17465 ||| NN
of  ||| S:17465 E:17468 ||| IN
single  ||| S:17468 E:17475 ||| JJ
copy  ||| S:17475 E:17480 ||| NN
transgenes  ||| S:17480 E:17491 ||| NN
to  ||| S:17491 E:17494 ||| TO
specific  ||| S:17494 E:17503 ||| JJ
genomic  ||| S:17503 E:17519 ||| JJ
sites  ||| S:17519 E:17525 ||| NNS
that  ||| S:17525 E:17530 ||| WDT
have  ||| S:17530 E:17535 ||| VBP
previously  ||| S:17535 E:17546 ||| RB
been  ||| S:17546 E:17551 ||| VBN
marked  ||| S:17551 E:17558 ||| VBN
by  ||| S:17558 E:17570 ||| IN
loxP  ||| S:17570 E:17575 ||| JJ
elements  ||| S:17575 E:17584 ||| NNS
has  ||| S:17584 E:17588 ||| VBZ
also  ||| S:17588 E:17593 ||| RB
been  ||| S:17593 E:17598 ||| VBN
described  ||| S:17598 E:17616 ||| VBN
both  ||| S:17616 E:17621 ||| DT
in  ||| S:17621 E:17624 ||| IN
somatic  ||| S:17624 E:17632 ||| JJ
cells  ||| S:17632 E:17638 ||| NNS
and  ||| S:17638 E:17642 ||| CC
more  ||| S:17642 E:17647 ||| RBR
recently  ||| S:17647 E:17656 ||| RB
in  ||| S:17656 E:17659 ||| IN
ES  ||| S:17659 E:17662 ||| NNP
cells  ||| S:17662 E:17668 ||| NNS
using  ||| S:17668 E:17674 ||| VBG
a  ||| S:17674 E:17684 ||| DT
double  ||| S:17684 E:17700 ||| JJ
LoxP  ||| S:17700 E:17705 ||| JJ
targeting  ||| S:17705 E:17715 ||| JJ
strategy  ||| S:17715 E:17724 ||| NN
[  ||| S:17724 E:17726 ||| -LRB-
22 ||| S:17726 E:17728 ||| CD
,  ||| S:17728 E:17730 ||| ,
23 ||| S:17730 E:17732 ||| CD
] ||| S:17732 E:17733 ||| -RRB-
.  ||| S:17733 E:17743 ||| .
Although  ||| S:17743 E:17752 ||| IN
this  ||| S:17752 E:17757 ||| DT
approach  ||| S:17757 E:17766 ||| NN
also  ||| S:17766 E:17771 ||| RB
results  ||| S:17771 E:17779 ||| NNS
in  ||| S:17779 E:17782 ||| IN
efficient  ||| S:17782 E:17792 ||| JJ
targeting  ||| S:17792 E:17810 ||| VBG
to  ||| S:17810 E:17813 ||| TO
a  ||| S:17813 E:17815 ||| DT
defined  ||| S:17815 E:17823 ||| JJ
genomic  ||| S:17823 E:17831 ||| NNS
locus  ||| S:17831 E:17837 ||| VBP
it  ||| S:17837 E:17840 ||| PRP
relies  ||| S:17840 E:17847 ||| VBZ
on  ||| S:17847 E:17850 ||| IN
co-transfection  ||| S:17850 E:17866 ||| JJ
of  ||| S:17866 E:17877 ||| IN
a  ||| S:17877 E:17879 ||| DT
Cre  ||| S:17879 E:17883 ||| JJ
expression  ||| S:17883 E:17894 ||| NN
plasmid  ||| S:17894 E:17902 ||| VBD
along  ||| S:17902 E:17908 ||| RP
with  ||| S:17908 E:17913 ||| IN
a  ||| S:17913 E:17924 ||| DT
loxP  ||| S:17924 E:17929 ||| JJ
-targeting  ||| S:17929 E:17940 ||| JJ
vector  ||| S:17940 E:17947 ||| NN
that  ||| S:17947 E:17952 ||| WDT
carries  ||| S:17952 E:17968 ||| VBZ
the  ||| S:17968 E:17972 ||| DT
transgene ||| S:17972 E:17981 ||| NN
.  ||| S:17981 E:17983 ||| .
Hardouin  ||| S:17983 E:18001 ||| FW
et  ||| S:18001 E:18004 ||| FW
al  ||| S:18004 E:18007 ||| VBZ
also  ||| S:18007 E:18012 ||| RB
recently  ||| S:18012 E:18021 ||| RB
described  ||| S:18021 E:18031 ||| VBD
an  ||| S:18031 E:18042 ||| DT
elegant  ||| S:18042 E:18050 ||| JJ
approach  ||| S:18050 E:18059 ||| NN
to  ||| S:18059 E:18062 ||| TO
introduce  ||| S:18062 E:18072 ||| VB
transgenes  ||| S:18072 E:18083 ||| VBN
to  ||| S:18083 E:18086 ||| TO
loci  ||| S:18086 E:18091 ||| VB
identified  ||| S:18091 E:18110 ||| VBN
by  ||| S:18110 E:18113 ||| IN
gene  ||| S:18113 E:18118 ||| NN
trapping ||| S:18118 E:18126 ||| NN
.  ||| S:18126 E:18128 ||| .
Here  ||| S:18128 E:18133 ||| RB
integration  ||| S:18133 E:18145 ||| NN
of  ||| S:18145 E:18148 ||| IN
the  ||| S:18148 E:18152 ||| DT
transgene  ||| S:18152 E:18162 ||| NN
at  ||| S:18162 E:18165 ||| IN
the  ||| S:18165 E:18177 ||| DT
gene-trap  ||| S:18177 E:18187 ||| JJ
locus  ||| S:18187 E:18193 ||| NN
was  ||| S:18193 E:18197 ||| VBD
again  ||| S:18197 E:18203 ||| RB
mediated  ||| S:18203 E:18212 ||| VBN
by  ||| S:18212 E:18215 ||| IN
Cre  ||| S:18215 E:18219 ||| NNP
recombinase  ||| S:18219 E:18231 ||| NN
and  ||| S:18231 E:18243 ||| CC
translation  ||| S:18243 E:18255 ||| NN
of  ||| S:18255 E:18258 ||| IN
the  ||| S:18258 E:18262 ||| DT
transgene  ||| S:18262 E:18272 ||| NN
was  ||| S:18272 E:18276 ||| VBD
facilitated  ||| S:18276 E:18288 ||| VBN
by  ||| S:18288 E:18291 ||| IN
an  ||| S:18291 E:18294 ||| DT
internal  ||| S:18294 E:18311 ||| JJ
ribosomal  ||| S:18311 E:18321 ||| JJ
entry  ||| S:18321 E:18327 ||| NN
site  ||| S:18327 E:18332 ||| NN
( ||| S:18332 E:18333 ||| -LRB-
IRES ||| S:18333 E:18337 ||| NNP
)  ||| S:18337 E:18339 ||| -RRB-
[  ||| S:18339 E:18341 ||| -LRB-
24 ||| S:18341 E:18343 ||| CD
] ||| S:18343 E:18344 ||| -RRB-
.  ||| S:18344 E:18346 ||| .
In  ||| S:18346 E:18349 ||| IN
contrast ||| S:18349 E:18357 ||| NN
,  ||| S:18357 E:18359 ||| ,
our  ||| S:18359 E:18371 ||| PRP$
approach  ||| S:18371 E:18380 ||| NN
relies  ||| S:18380 E:18387 ||| VBZ
simply  ||| S:18387 E:18394 ||| RB
on  ||| S:18394 E:18397 ||| IN
the  ||| S:18397 E:18401 ||| DT
reconstitution  ||| S:18401 E:18416 ||| NN
of  ||| S:18416 E:18419 ||| IN
resistance  ||| S:18419 E:18438 ||| NN
to  ||| S:18438 E:18441 ||| TO
G418  ||| S:18441 E:18446 ||| CD
and  ||| S:18446 E:18450 ||| CC
can  ||| S:18450 E:18454 ||| MD
be  ||| S:18454 E:18457 ||| VB
used  ||| S:18457 E:18462 ||| VBN
to  ||| S:18462 E:18465 ||| TO
target  ||| S:18465 E:18472 ||| VB
transgenes  ||| S:18472 E:18483 ||| VBN
to  ||| S:18483 E:18486 ||| TO
any  ||| S:18486 E:18490 ||| DT
genomic  ||| S:18490 E:18506 ||| JJ
locus ||| S:18506 E:18511 ||| NN
.  ||| S:18511 E:18521 ||| .
Transgenic  ||| S:18521 E:18532 ||| NNP
mice  ||| S:18532 E:18537 ||| NNS
are  ||| S:18537 E:18541 ||| VBP
often  ||| S:18541 E:18547 ||| RB
used  ||| S:18547 E:18552 ||| VBN
to  ||| S:18552 E:18555 ||| TO
examine  ||| S:18555 E:18563 ||| VB
gene  ||| S:18563 E:18568 ||| NN
function  ||| S:18568 E:18585 ||| NN
through  ||| S:18585 E:18593 ||| IN
ectopic  ||| S:18593 E:18601 ||| JJ
expression  ||| S:18601 E:18612 ||| NN
studies ||| S:18612 E:18619 ||| NNS
.  ||| S:18619 E:18621 ||| .
This  ||| S:18621 E:18626 ||| DT
requires  ||| S:18626 E:18635 ||| VBZ
the  ||| S:18635 E:18647 ||| DT
availability  ||| S:18647 E:18660 ||| NN
of  ||| S:18660 E:18663 ||| IN
characterized  ||| S:18663 E:18677 ||| JJ
transcriptional  ||| S:18677 E:18693 ||| JJ
regulatory  ||| S:18693 E:18712 ||| JJ
elements  ||| S:18712 E:18721 ||| NNS
that  ||| S:18721 E:18726 ||| WDT
are  ||| S:18726 E:18730 ||| VBP
capable  ||| S:18730 E:18738 ||| JJ
of  ||| S:18738 E:18741 ||| IN
expressing  ||| S:18741 E:18752 ||| VBG
transgenes  ||| S:18752 E:18763 ||| NN
in  ||| S:18763 E:18766 ||| IN
the  ||| S:18766 E:18778 ||| DT
tissue  ||| S:18778 E:18785 ||| NN
of  ||| S:18785 E:18788 ||| IN
choice ||| S:18788 E:18794 ||| NN
.  ||| S:18794 E:18796 ||| .
In  ||| S:18796 E:18799 ||| IN
addition ||| S:18799 E:18807 ||| NN
,  ||| S:18807 E:18809 ||| ,
for  ||| S:18809 E:18813 ||| IN
developmental  ||| S:18813 E:18827 ||| JJ
studies ||| S:18827 E:18834 ||| NNS
,  ||| S:18834 E:18844 ||| ,
the  ||| S:18844 E:18848 ||| DT
transcriptional  ||| S:18848 E:18864 ||| JJ
regulatory  ||| S:18864 E:18875 ||| JJ
elements  ||| S:18875 E:18884 ||| NNS
have  ||| S:18884 E:18889 ||| VBP
to  ||| S:18889 E:18892 ||| TO
ensure  ||| S:18892 E:18907 ||| VB
transgene  ||| S:18907 E:18917 ||| JJ
expression  ||| S:18917 E:18928 ||| NN
during  ||| S:18928 E:18935 ||| IN
the  ||| S:18935 E:18939 ||| DT
correct  ||| S:18939 E:18947 ||| JJ
developmental  ||| S:18947 E:18961 ||| JJ
time  ||| S:18961 E:18974 ||| NN
frame ||| S:18974 E:18979 ||| NN
.  ||| S:18979 E:18981 ||| .
Although  ||| S:18981 E:18990 ||| IN
the  ||| S:18990 E:18994 ||| DT
expression  ||| S:18994 E:19005 ||| NN
patterns  ||| S:19005 E:19014 ||| NNS
of  ||| S:19014 E:19017 ||| IN
many  ||| S:19017 E:19022 ||| JJ
genes  ||| S:19022 E:19028 ||| NNS
have  ||| S:19028 E:19041 ||| VBP
been  ||| S:19041 E:19046 ||| VBN
described  ||| S:19046 E:19056 ||| VBN
in  ||| S:19056 E:19059 ||| IN
detail ||| S:19059 E:19065 ||| NN
,  ||| S:19065 E:19067 ||| ,
characterization  ||| S:19067 E:19084 ||| NN
of  ||| S:19084 E:19087 ||| IN
promoter  ||| S:19087 E:19096 ||| NN
and  ||| S:19096 E:19108 ||| CC
enhancer  ||| S:19108 E:19117 ||| JJ
elements  ||| S:19117 E:19126 ||| NNS
that  ||| S:19126 E:19131 ||| WDT
control  ||| S:19131 E:19139 ||| VBP
this  ||| S:19139 E:19144 ||| DT
expression  ||| S:19144 E:19155 ||| NN
is  ||| S:19155 E:19158 ||| VBZ
much  ||| S:19158 E:19163 ||| RB
more  ||| S:19163 E:19176 ||| RBR
limited ||| S:19176 E:19183 ||| JJ
.  ||| S:19183 E:19185 ||| .
This  ||| S:19185 E:19190 ||| DT
is  ||| S:19190 E:19193 ||| VBZ
partly  ||| S:19193 E:19200 ||| RB
due  ||| S:19200 E:19204 ||| JJ
to  ||| S:19204 E:19207 ||| TO
the  ||| S:19207 E:19211 ||| DT
fact  ||| S:19211 E:19216 ||| NN
that  ||| S:19216 E:19221 ||| IN
complex  ||| S:19221 E:19237 ||| JJ
expression  ||| S:19237 E:19248 ||| NN
patterns  ||| S:19248 E:19257 ||| NNS
often  ||| S:19257 E:19263 ||| RB
utilize  ||| S:19263 E:19271 ||| VB
genomic  ||| S:19271 E:19279 ||| JJ
regulatory  ||| S:19279 E:19298 ||| JJ
sequences  ||| S:19298 E:19308 ||| NN
that  ||| S:19308 E:19313 ||| WDT
are  ||| S:19313 E:19317 ||| VBP
positioned  ||| S:19317 E:19328 ||| VBN
many  ||| S:19328 E:19333 ||| JJ
kilobases  ||| S:19333 E:19343 ||| NNS
away  ||| S:19343 E:19348 ||| RB
from  ||| S:19348 E:19353 ||| IN
the  ||| S:19353 E:19365 ||| DT
gene  ||| S:19365 E:19370 ||| NN
making  ||| S:19370 E:19377 ||| VBG
them  ||| S:19377 E:19382 ||| PRP
difficult  ||| S:19382 E:19392 ||| JJ
to  ||| S:19392 E:19395 ||| TO
identify ||| S:19395 E:19403 ||| VB
.  ||| S:19403 E:19405 ||| .
However ||| S:19405 E:19412 ||| RB
,  ||| S:19412 E:19414 ||| ,
the  ||| S:19414 E:19426 ||| DT
introduction  ||| S:19426 E:19439 ||| NN
of  ||| S:19439 E:19442 ||| IN
transgenes  ||| S:19442 E:19453 ||| NN
into  ||| S:19453 E:19458 ||| IN
specific  ||| S:19458 E:19467 ||| JJ
loci  ||| S:19467 E:19472 ||| NN
allows  ||| S:19472 E:19479 ||| VBZ
the  ||| S:19479 E:19491 ||| DT
utilization  ||| S:19491 E:19503 ||| NN
of  ||| S:19503 E:19506 ||| IN
intact  ||| S:19506 E:19513 ||| JJ
endogenous  ||| S:19513 E:19524 ||| NNS
transcription  ||| S:19524 E:19538 ||| VBP
regulatory  ||| S:19538 E:19557 ||| JJ
sequences ||| S:19557 E:19566 ||| NN
,  ||| S:19566 E:19568 ||| ,
which  ||| S:19568 E:19574 ||| WDT
increases  ||| S:19574 E:19584 ||| VBZ
the  ||| S:19584 E:19588 ||| DT
likelihood  ||| S:19588 E:19599 ||| NN
that  ||| S:19599 E:19604 ||| IN
the  ||| S:19604 E:19616 ||| DT
transgene  ||| S:19616 E:19626 ||| NN
will  ||| S:19626 E:19631 ||| MD
be  ||| S:19631 E:19634 ||| VB
expressed  ||| S:19634 E:19644 ||| VBN
in  ||| S:19644 E:19647 ||| IN
the  ||| S:19647 E:19651 ||| DT
expected  ||| S:19651 E:19660 ||| JJ
fashion ||| S:19660 E:19667 ||| NN
.  ||| S:19667 E:19677 ||| .
Using  ||| S:19677 E:19683 ||| VBG
targeted  ||| S:19683 E:19692 ||| VBN
ES  ||| S:19692 E:19695 ||| NNP
cells  ||| S:19695 E:19701 ||| NNS
also  ||| S:19701 E:19706 ||| RB
provides  ||| S:19706 E:19715 ||| VBZ
the  ||| S:19715 E:19719 ||| DT
potential  ||| S:19719 E:19729 ||| NN
of  ||| S:19729 E:19740 ||| IN
expressing  ||| S:19740 E:19751 ||| VBG
lethal  ||| S:19751 E:19758 ||| JJ
transgenes ||| S:19758 E:19768 ||| NN
.  ||| S:19768 E:19770 ||| .
This  ||| S:19770 E:19775 ||| DT
may  ||| S:19775 E:19779 ||| MD
be  ||| S:19779 E:19782 ||| VB
important  ||| S:19782 E:19792 ||| JJ
for  ||| S:19792 E:19804 ||| IN
examining  ||| S:19804 E:19814 ||| VBG
the  ||| S:19814 E:19818 ||| DT
effects  ||| S:19818 E:19826 ||| NNS
of  ||| S:19826 E:19829 ||| IN
expressing  ||| S:19829 E:19840 ||| VBG
gain-of-function  ||| S:19840 E:19857 ||| JJ
or  ||| S:19857 E:19868 ||| CC
dominant-negative  ||| S:19868 E:19886 ||| JJ
alleles  ||| S:19886 E:19894 ||| NN
of  ||| S:19894 E:19897 ||| IN
a  ||| S:19897 E:19899 ||| DT
gene  ||| S:19899 E:19904 ||| NN
product ||| S:19904 E:19911 ||| NN
.  ||| S:19911 E:19913 ||| .
This  ||| S:19913 E:19918 ||| DT
is  ||| S:19918 E:19929 ||| VBZ
difficult  ||| S:19929 E:19939 ||| JJ
using  ||| S:19939 E:19945 ||| VBG
a  ||| S:19945 E:19947 ||| DT
conventional  ||| S:19947 E:19960 ||| JJ
approach  ||| S:19960 E:19969 ||| NN
because  ||| S:19969 E:19977 ||| IN
of  ||| S:19977 E:19980 ||| IN
the  ||| S:19980 E:19984 ||| DT
need  ||| S:19984 E:19997 ||| NN
to  ||| S:19997 E:20000 ||| TO
establish  ||| S:20000 E:20010 ||| VB
founder  ||| S:20010 E:20018 ||| NN
mice  ||| S:20018 E:20023 ||| NNS
expressing  ||| S:20023 E:20034 ||| VBG
the  ||| S:20034 E:20038 ||| DT
transgene ||| S:20038 E:20047 ||| NN
.  ||| S:20047 E:20057 ||| .
However ||| S:20057 E:20064 ||| RB
,  ||| S:20064 E:20066 ||| ,
if  ||| S:20066 E:20069 ||| IN
a  ||| S:20069 E:20071 ||| DT
line  ||| S:20071 E:20076 ||| NN
of  ||| S:20076 E:20079 ||| IN
"transgenic ||| S:20079 E:20090 ||| NNP
"  ||| S:20090 E:20092 ||| ''
ES  ||| S:20092 E:20095 ||| NNP
cells  ||| S:20095 E:20101 ||| NNS
can  ||| S:20101 E:20105 ||| MD
be  ||| S:20105 E:20116 ||| VB
established  ||| S:20116 E:20128 ||| VBN
then  ||| S:20128 E:20133 ||| RB
it  ||| S:20133 E:20136 ||| PRP
is  ||| S:20136 E:20139 ||| VBZ
possible  ||| S:20139 E:20148 ||| JJ
to  ||| S:20148 E:20151 ||| TO
generate  ||| S:20151 E:20160 ||| VB
clonal  ||| S:20160 E:20167 ||| JJ
embryos  ||| S:20167 E:20183 ||| NNS
directly  ||| S:20183 E:20192 ||| RB
from  ||| S:20192 E:20197 ||| IN
these  ||| S:20197 E:20203 ||| DT
ES  ||| S:20203 E:20206 ||| NNP
cells  ||| S:20206 E:20212 ||| NNS
by  ||| S:20212 E:20215 ||| IN
aggregating  ||| S:20215 E:20227 ||| VBG
them  ||| S:20227 E:20232 ||| PRP
with  ||| S:20232 E:20245 ||| IN
tetraploid  ||| S:20245 E:20256 ||| JJ
embryos ||| S:20256 E:20263 ||| NN
.  ||| S:20263 E:20265 ||| .
Indeed ||| S:20265 E:20271 ||| RB
,  ||| S:20271 E:20273 ||| ,
here  ||| S:20273 E:20278 ||| RB
we  ||| S:20278 E:20281 ||| PRP
have  ||| S:20281 E:20286 ||| VBP
used  ||| S:20286 E:20291 ||| VBN
this  ||| S:20291 E:20296 ||| DT
approach  ||| S:20296 E:20313 ||| NN
to  ||| S:20313 E:20316 ||| TO
establish  ||| S:20316 E:20326 ||| VB
that  ||| S:20326 E:20331 ||| IN
the  ||| S:20331 E:20335 ||| DT
introduction  ||| S:20335 E:20348 ||| NN
of  ||| S:20348 E:20351 ||| IN
a  ||| S:20351 E:20362 ||| DT
LacZ  ||| S:20362 E:20367 ||| JJ
transgene  ||| S:20367 E:20377 ||| NN
into  ||| S:20377 E:20382 ||| IN
the  ||| S:20382 E:20395 ||| DT
Hnf3  ||| S:20395 E:20400 ||| FW
α  ||| S:20400 E:20402 ||| FW
locus  ||| S:20402 E:20408 ||| FW
facilitates  ||| S:20408 E:20420 ||| FW
transgene  ||| S:20420 E:20438 ||| FW
expression  ||| S:20438 E:20449 ||| NN
throughout  ||| S:20449 E:20460 ||| IN
the  ||| S:20460 E:20464 ||| DT
developing  ||| S:20464 E:20475 ||| VBG
gut  ||| S:20475 E:20479 ||| NN
( ||| S:20479 E:20480 ||| -LRB-
Fig  ||| S:20480 E:20484 ||| NNP
4 ||| S:20484 E:20485 ||| CD
) ||| S:20485 E:20486 ||| -RRB-
.  ||| S:20486 E:20496 ||| .
In  ||| S:20496 E:20499 ||| IN
sum ||| S:20499 E:20502 ||| NN
,  ||| S:20502 E:20504 ||| ,
we  ||| S:20504 E:20507 ||| PRP
have  ||| S:20507 E:20512 ||| VBP
described  ||| S:20512 E:20522 ||| VBN
a  ||| S:20522 E:20524 ||| DT
method  ||| S:20524 E:20531 ||| NN
that  ||| S:20531 E:20536 ||| IN
facilitates  ||| S:20536 E:20548 ||| VBG
the  ||| S:20548 E:20560 ||| DT
efficient  ||| S:20560 E:20570 ||| JJ
introduction  ||| S:20570 E:20583 ||| NN
of  ||| S:20583 E:20586 ||| IN
transgenes  ||| S:20586 E:20597 ||| NN
into  ||| S:20597 E:20602 ||| IN
predefined  ||| S:20602 E:20613 ||| JJ
loci  ||| S:20613 E:20626 ||| NN
in  ||| S:20626 E:20629 ||| IN
the  ||| S:20629 E:20633 ||| DT
mouse  ||| S:20633 E:20639 ||| NN
genome ||| S:20639 E:20645 ||| NN
.  ||| S:20645 E:20647 ||| .
By  ||| S:20647 E:20650 ||| IN
selecting  ||| S:20650 E:20660 ||| VBG
appropriate  ||| S:20660 E:20672 ||| JJ
sequences  ||| S:20672 E:20682 ||| NN
for  ||| S:20682 E:20694 ||| IN
homologous  ||| S:20694 E:20705 ||| RB
recombination  ||| S:20705 E:20719 ||| VB
this  ||| S:20719 E:20724 ||| DT
approach  ||| S:20724 E:20733 ||| NN
can  ||| S:20733 E:20737 ||| MD
be  ||| S:20737 E:20740 ||| VB
tailored  ||| S:20740 E:20757 ||| VBN
toward  ||| S:20757 E:20764 ||| IN
any  ||| S:20764 E:20768 ||| DT
specific  ||| S:20768 E:20777 ||| JJ
genomic  ||| S:20777 E:20785 ||| JJ
locus ||| S:20785 E:20790 ||| NN
.  ||| S:20790 E:20792 ||| .
We ||| S:20792 E:20794 ||| PRP
,  ||| S:20794 E:20796 ||| ,
therefore ||| S:20796 E:20805 ||| RB
,  ||| S:20805 E:20807 ||| ,
believe  ||| S:20807 E:20823 ||| VBP
that  ||| S:20823 E:20828 ||| IN
this  ||| S:20828 E:20833 ||| DT
approach  ||| S:20833 E:20842 ||| NN
expands  ||| S:20842 E:20850 ||| VBZ
the  ||| S:20850 E:20854 ||| DT
repertoire  ||| S:20854 E:20865 ||| NN
of  ||| S:20865 E:20868 ||| IN
tools  ||| S:20868 E:20882 ||| NNS
available  ||| S:20882 E:20892 ||| JJ
for  ||| S:20892 E:20896 ||| IN
genetic  ||| S:20896 E:20904 ||| JJ
manipulation  ||| S:20904 E:20917 ||| NN
in  ||| S:20917 E:20920 ||| IN
the  ||| S:20920 E:20924 ||| DT
mouse  ||| S:20924 E:20930 ||| NN
and  ||| S:20930 E:20934 ||| CC
will  ||| S:20934 E:20947 ||| MD
enhance  ||| S:20947 E:20955 ||| VB
our  ||| S:20955 E:20959 ||| PRP$
ability  ||| S:20959 E:20967 ||| NN
to  ||| S:20967 E:20970 ||| TO
address  ||| S:20970 E:20978 ||| VB
gene  ||| S:20978 E:20983 ||| NN
function  ||| S:20983 E:20992 ||| NN
in  ||| S:20992 E:21003 ||| IN
mammals ||| S:21003 E:21010 ||| NN
.  ||| S:21010 E:21034 ||| .
Materials  ||| S:21034 E:21044 ||| NNS
and  ||| S:21044 E:21048 ||| CC
Methods  ||| S:21048 E:21075 ||| NNP
Plasmids  ||| S:21075 E:21107 ||| NNP
Hnf3α  ||| S:21107 E:21113 ||| FW
targeting  ||| S:21113 E:21123 ||| FW
vector ||| S:21123 E:21129 ||| FW
( ||| S:21129 E:21130 ||| -LRB-
p3αloxPNeo-TK ||| S:21130 E:21143 ||| NNP
)  ||| S:21143 E:21157 ||| -RRB-
A  ||| S:21157 E:21159 ||| DT
900  ||| S:21159 E:21163 ||| CD
bp  ||| S:21163 E:21166 ||| CD
Xho1 ||| S:21166 E:21170 ||| CD
/ ||| S:21170 E:21171 ||| CD
Xba1  ||| S:21171 E:21176 ||| CD
fragment  ||| S:21176 E:21185 ||| NN
of  ||| S:21185 E:21188 ||| IN
Hnf3α  ||| S:21188 E:21194 ||| CD
genomic  ||| S:21194 E:21202 ||| JJ
DNA  ||| S:21202 E:21218 ||| NN
that  ||| S:21218 E:21223 ||| WDT
included  ||| S:21223 E:21232 ||| VBD
exon  ||| S:21232 E:21237 ||| CD
1  ||| S:21237 E:21239 ||| CD
and  ||| S:21239 E:21243 ||| CC
a  ||| S:21243 E:21245 ||| DT
portion  ||| S:21245 E:21253 ||| NN
of  ||| S:21253 E:21256 ||| IN
intron  ||| S:21256 E:21263 ||| CD
1  ||| S:21263 E:21265 ||| CD
was  ||| S:21265 E:21269 ||| VBD
used  ||| S:21269 E:21286 ||| VBN
as  ||| S:21286 E:21289 ||| IN
the  ||| S:21289 E:21293 ||| DT
5 ||| S:21293 E:21294 ||| CD
'  ||| S:21294 E:21296 ||| POS
arm  ||| S:21296 E:21300 ||| NN
of  ||| S:21300 E:21303 ||| IN
homology ||| S:21303 E:21311 ||| NN
.  ||| S:21311 E:21313 ||| .
The  ||| S:21313 E:21317 ||| DT
3 ||| S:21317 E:21318 ||| CD
'  ||| S:21318 E:21320 ||| POS
arm  ||| S:21320 E:21324 ||| NN
of  ||| S:21324 E:21327 ||| IN
homology  ||| S:21327 E:21336 ||| NN
was  ||| S:21336 E:21352 ||| VBD
cloned  ||| S:21352 E:21359 ||| VBN
as  ||| S:21359 E:21362 ||| IN
a  ||| S:21362 E:21364 ||| DT
4.5  ||| S:21364 E:21368 ||| CD
kb  ||| S:21368 E:21371 ||| CD
Xho1  ||| S:21371 E:21376 ||| CD
fragment  ||| S:21376 E:21385 ||| NN
of  ||| S:21385 E:21388 ||| IN
Hnf3α  ||| S:21388 E:21394 ||| CD
genomic  ||| S:21394 E:21402 ||| JJ
DNA ||| S:21402 E:21405 ||| NN
.  ||| S:21405 E:21419 ||| .
A  ||| S:21419 E:21421 ||| DT
Xho1 ||| S:21421 E:21425 ||| NNP
/ ||| S:21425 E:21426 ||| NNP
HindIII  ||| S:21426 E:21434 ||| NNP
( ||| S:21434 E:21435 ||| -LRB-
blunt ||| S:21435 E:21440 ||| LS
)  ||| S:21440 E:21442 ||| -RRB-
cassette  ||| S:21442 E:21451 ||| VBP
containing  ||| S:21451 E:21462 ||| VBG
the  ||| S:21462 E:21466 ||| DT
Tn5  ||| S:21466 E:21483 ||| FW
neomycin  ||| S:21483 E:21492 ||| FW
phosphotransferase  ||| S:21492 E:21511 ||| FW
(  ||| S:21511 E:21526 ||| -LRB-
Neo  ||| S:21526 E:21530 ||| NNP
) ||| S:21530 E:21531 ||| -RRB-
gene ||| S:21531 E:21535 ||| NN
,  ||| S:21535 E:21537 ||| ,
that  ||| S:21537 E:21542 ||| WDT
could  ||| S:21542 E:21548 ||| MD
confer  ||| S:21548 E:21567 ||| VB
resistance  ||| S:21567 E:21578 ||| NN
to  ||| S:21578 E:21581 ||| TO
G418  ||| S:21581 E:21586 ||| CD
and  ||| S:21586 E:21590 ||| CC
whose  ||| S:21590 E:21596 ||| WP$
expression  ||| S:21596 E:21607 ||| NN
in  ||| S:21607 E:21610 ||| IN
mammalian  ||| S:21610 E:21632 ||| JJ
cells  ||| S:21632 E:21638 ||| NNS
was  ||| S:21638 E:21642 ||| VBD
directed  ||| S:21642 E:21651 ||| VBN
by  ||| S:21651 E:21654 ||| IN
a  ||| S:21654 E:21669 ||| DT
phosphoglycerate  ||| S:21669 E:21686 ||| JJ
kinase-1  ||| S:21686 E:21695 ||| NNP
(  ||| S:21695 E:21710 ||| -LRB-
pgk ||| S:21710 E:21713 ||| LS
)  ||| S:21713 E:21715 ||| -RRB-
promoter ||| S:21715 E:21723 ||| NN
,  ||| S:21723 E:21725 ||| ,
was  ||| S:21725 E:21729 ||| VBD
introduced  ||| S:21729 E:21752 ||| VBN
into  ||| S:21752 E:21757 ||| IN
an  ||| S:21757 E:21760 ||| DT
XbaI  ||| S:21760 E:21765 ||| JJ
( ||| S:21765 E:21766 ||| -LRB-
blunt ||| S:21766 E:21771 ||| LS
)  ||| S:21771 E:21773 ||| -RRB-
site  ||| S:21773 E:21778 ||| NN
between  ||| S:21778 E:21786 ||| IN
the  ||| S:21786 E:21790 ||| DT
Hnf3α  ||| S:21790 E:21796 ||| FW
genomic  ||| S:21796 E:21816 ||| FW
sequences  ||| S:21816 E:21826 ||| FW
[  ||| S:21826 E:21828 ||| -LRB-
16 ||| S:21828 E:21830 ||| CD
,  ||| S:21830 E:21832 ||| ,
25 ||| S:21832 E:21834 ||| CD
] ||| S:21834 E:21835 ||| -RRB-
.  ||| S:21835 E:21837 ||| .
The  ||| S:21837 E:21854 ||| DT
pgk  ||| S:21854 E:21858 ||| JJ
promoter  ||| S:21858 E:21867 ||| NN
was  ||| S:21867 E:21871 ||| VBD
flanked  ||| S:21871 E:21879 ||| VBN
by  ||| S:21879 E:21895 ||| IN
loxP  ||| S:21895 E:21900 ||| JJ
elements  ||| S:21900 E:21909 ||| NNS
so  ||| S:21909 E:21912 ||| RB
that  ||| S:21912 E:21917 ||| IN
it  ||| S:21917 E:21920 ||| PRP
could  ||| S:21920 E:21926 ||| MD
be  ||| S:21926 E:21941 ||| VB
deleted  ||| S:21941 E:21949 ||| VBN
by  ||| S:21949 E:21952 ||| IN
the  ||| S:21952 E:21956 ||| DT
action  ||| S:21956 E:21963 ||| NN
of  ||| S:21963 E:21966 ||| IN
Cre  ||| S:21966 E:21970 ||| NNP
recombinase ||| S:21970 E:21981 ||| NN
.  ||| S:21981 E:21983 ||| .
The  ||| S:21983 E:22000 ||| DT
herpes  ||| S:22000 E:22007 ||| FW
simplex  ||| S:22007 E:22015 ||| FW
virus  ||| S:22015 E:22021 ||| FW
thymidine  ||| S:22021 E:22043 ||| FW
kinase  ||| S:22043 E:22050 ||| FW
(  ||| S:22050 E:22065 ||| -LRB-
hsv-TK  ||| S:22065 E:22072 ||| NNP
)  ||| S:22072 E:22074 ||| -RRB-
gene ||| S:22074 E:22078 ||| NN
,  ||| S:22078 E:22080 ||| ,
whose  ||| S:22080 E:22086 ||| WP$
expression  ||| S:22086 E:22109 ||| NN
was  ||| S:22109 E:22113 ||| VBD
also  ||| S:22113 E:22118 ||| RB
regulated  ||| S:22118 E:22128 ||| VBN
by  ||| S:22128 E:22131 ||| IN
the  ||| S:22131 E:22148 ||| DT
pgk  ||| S:22148 E:22152 ||| JJ
promoter ||| S:22152 E:22160 ||| NN
,  ||| S:22160 E:22162 ||| ,
was  ||| S:22162 E:22166 ||| VBD
introduced  ||| S:22166 E:22189 ||| VBN
adjacent  ||| S:22189 E:22198 ||| JJ
to  ||| S:22198 E:22201 ||| TO
the  ||| S:22201 E:22205 ||| DT
Hnf3α  ||| S:22205 E:22211 ||| CD
5 ||| S:22211 E:22212 ||| CD
'  ||| S:22212 E:22214 ||| POS
arm  ||| S:22214 E:22218 ||| NN
of  ||| S:22218 E:22221 ||| IN
homology  ||| S:22221 E:22230 ||| VBG
to  ||| S:22230 E:22233 ||| TO
provide  ||| S:22233 E:22253 ||| VB
negative  ||| S:22253 E:22262 ||| JJ
selection  ||| S:22262 E:22272 ||| NN
in  ||| S:22272 E:22275 ||| IN
the  ||| S:22275 E:22279 ||| DT
presence  ||| S:22279 E:22288 ||| NN
of  ||| S:22288 E:22291 ||| IN
gancylovir ||| S:22291 E:22301 ||| NN
.  ||| S:22301 E:22337 ||| .
Transgene  ||| S:22337 E:22347 ||| FW
targeting  ||| S:22347 E:22357 ||| FW
vector  ||| S:22357 E:22364 ||| FW
( ||| S:22364 E:22365 ||| -LRB-
p3αΔNeo ||| S:22365 E:22372 ||| NNP
)  ||| S:22372 E:22386 ||| -RRB-
The  ||| S:22386 E:22390 ||| DT
transgene-targeting  ||| S:22390 E:22410 ||| JJ
vector  ||| S:22410 E:22417 ||| NN
used  ||| S:22417 E:22422 ||| VBN
in  ||| S:22422 E:22425 ||| IN
these  ||| S:22425 E:22443 ||| DT
experiments  ||| S:22443 E:22455 ||| NNS
was  ||| S:22455 E:22459 ||| VBD
generated  ||| S:22459 E:22469 ||| VBN
in  ||| S:22469 E:22472 ||| IN
multiple  ||| S:22472 E:22481 ||| JJ
steps  ||| S:22481 E:22487 ||| NNS
( ||| S:22487 E:22488 ||| -LRB-
Fig  ||| S:22488 E:22492 ||| NNP
2 ||| S:22492 E:22493 ||| CD
) ||| S:22493 E:22494 ||| -RRB-
.  ||| S:22494 E:22496 ||| .
A  ||| S:22496 E:22510 ||| DT
NotI ||| S:22510 E:22514 ||| JJ
/ ||| S:22514 E:22515 ||| NNP
RsrII  ||| S:22515 E:22521 ||| NNP
( ||| S:22521 E:22522 ||| -LRB-
blunt ||| S:22522 E:22527 ||| LS
) ||| S:22527 E:22528 ||| -RRB-
1.4  ||| S:22528 E:22532 ||| CD
kb  ||| S:22532 E:22535 ||| NNS
cassette  ||| S:22535 E:22544 ||| VBP
containing  ||| S:22544 E:22555 ||| VBG
the  ||| S:22555 E:22559 ||| DT
5 ||| S:22559 E:22560 ||| CD
'  ||| S:22560 E:22562 ||| POS
end  ||| S:22562 E:22578 ||| NN
of  ||| S:22578 E:22594 ||| IN
Neo  ||| S:22594 E:22598 ||| NNP
coding  ||| S:22598 E:22605 ||| NNS
sequence  ||| S:22605 E:22614 ||| VBP
accompanied  ||| S:22614 E:22638 ||| VBN
by  ||| S:22638 E:22641 ||| IN
the  ||| S:22641 E:22658 ||| DT
pgk  ||| S:22658 E:22662 ||| JJ
promoter  ||| S:22662 E:22671 ||| NN
with  ||| S:22671 E:22676 ||| IN
flanking  ||| S:22676 E:22698 ||| JJ
loxP  ||| S:22698 E:22703 ||| JJ
elements  ||| S:22703 E:22712 ||| NNS
was  ||| S:22712 E:22716 ||| VBD
introduced  ||| S:22716 E:22727 ||| VBN
into  ||| S:22727 E:22744 ||| IN
the  ||| S:22744 E:22748 ||| DT
SphI  ||| S:22748 E:22753 ||| JJ
site  ||| S:22753 E:22758 ||| NN
( ||| S:22758 E:22759 ||| -LRB-
blunt ||| S:22759 E:22764 ||| LS
)  ||| S:22764 E:22766 ||| -RRB-
of  ||| S:22766 E:22769 ||| IN
pNEB193  ||| S:22769 E:22777 ||| NNP
( ||| S:22777 E:22778 ||| -LRB-
New  ||| S:22778 E:22782 ||| NNP
England  ||| S:22782 E:22790 ||| NNP
Biolabs ||| S:22790 E:22797 ||| NNP
) ||| S:22797 E:22798 ||| -RRB-
.  ||| S:22798 E:22812 ||| .
Deletion  ||| S:22812 E:22821 ||| NNP
of  ||| S:22821 E:22824 ||| IN
the  ||| S:22824 E:22828 ||| DT
49  ||| S:22828 E:22831 ||| CD
c-terminal  ||| S:22831 E:22842 ||| JJ
codons  ||| S:22842 E:22849 ||| NN
of  ||| S:22849 E:22852 ||| IN
the  ||| S:22852 E:22869 ||| DT
Neo  ||| S:22869 E:22873 ||| JJ
gene  ||| S:22873 E:22878 ||| NN
disrupted  ||| S:22878 E:22888 ||| VBD
its  ||| S:22888 E:22892 ||| PRP$
ability  ||| S:22892 E:22900 ||| NN
to  ||| S:22900 E:22915 ||| TO
encode  ||| S:22915 E:22922 ||| VB
resistance  ||| S:22922 E:22933 ||| NN
to  ||| S:22933 E:22936 ||| TO
G418  ||| S:22936 E:22941 ||| CD
( ||| S:22941 E:22942 ||| -LRB-
data  ||| S:22942 E:22947 ||| NNS
not  ||| S:22947 E:22951 ||| RB
shown ||| S:22951 E:22956 ||| VBN
)  ||| S:22956 E:22958 ||| -RRB-
[  ||| S:22958 E:22960 ||| -LRB-
16 ||| S:22960 E:22962 ||| CD
] ||| S:22962 E:22963 ||| -RRB-
.  ||| S:22963 E:22965 ||| .
This  ||| S:22965 E:22982 ||| DT
sub-fragment  ||| S:22982 E:22995 ||| JJ
of  ||| S:22995 E:23011 ||| IN
Neo  ||| S:23011 E:23015 ||| NNP
provided  ||| S:23015 E:23024 ||| VBD
the  ||| S:23024 E:23028 ||| DT
3 ||| S:23028 E:23029 ||| CD
'  ||| S:23029 E:23031 ||| POS
arm  ||| S:23031 E:23035 ||| NN
of  ||| S:23035 E:23050 ||| IN
homology  ||| S:23050 E:23059 ||| NN
in  ||| S:23059 E:23062 ||| IN
the  ||| S:23062 E:23066 ||| DT
targeting  ||| S:23066 E:23076 ||| JJ
vector ||| S:23076 E:23082 ||| NN
.  ||| S:23082 E:23084 ||| .
A  ||| S:23084 E:23086 ||| DT
530  ||| S:23086 E:23090 ||| CD
bp  ||| S:23090 E:23093 ||| CD
EcoRI  ||| S:23093 E:23111 ||| JJ
fragment  ||| S:23111 E:23120 ||| NN
( ||| S:23120 E:23121 ||| -LRB-
blunt ||| S:23121 E:23126 ||| LS
)  ||| S:23126 E:23128 ||| -RRB-
containing  ||| S:23128 E:23139 ||| VBG
an  ||| S:23139 E:23142 ||| DT
intron  ||| S:23142 E:23149 ||| NN
from  ||| S:23149 E:23154 ||| IN
the  ||| S:23154 E:23158 ||| DT
mouse  ||| S:23158 E:23176 ||| NN
protamine  ||| S:23176 E:23186 ||| NN
gene  ||| S:23186 E:23191 ||| NN
as  ||| S:23191 E:23194 ||| IN
well  ||| S:23194 E:23199 ||| RB
as  ||| S:23199 E:23202 ||| IN
poly ||| S:23202 E:23206 ||| NNS
( ||| S:23206 E:23207 ||| -LRB-
A ||| S:23207 E:23208 ||| NNP
)  ||| S:23208 E:23210 ||| -RRB-
addition  ||| S:23210 E:23219 ||| NN
sequences  ||| S:23219 E:23241 ||| NNS
was  ||| S:23241 E:23245 ||| VBD
isolated  ||| S:23245 E:23254 ||| VBN
from  ||| S:23254 E:23259 ||| IN
the  ||| S:23259 E:23263 ||| DT
plasmid  ||| S:23263 E:23271 ||| JJ
pLacF  ||| S:23271 E:23277 ||| JJ
and  ||| S:23277 E:23281 ||| CC
cloned  ||| S:23281 E:23288 ||| VBN
into  ||| S:23288 E:23293 ||| IN
the  ||| S:23293 E:23309 ||| DT
PmeI  ||| S:23309 E:23314 ||| JJ
site  ||| S:23314 E:23319 ||| NN
( ||| S:23319 E:23320 ||| -LRB-
blunt ||| S:23320 E:23325 ||| LS
)  ||| S:23325 E:23327 ||| -RRB-
of  ||| S:23327 E:23330 ||| IN
the  ||| S:23330 E:23334 ||| DT
preceding  ||| S:23334 E:23344 ||| JJ
plasmid  ||| S:23344 E:23352 ||| NNS
[  ||| S:23352 E:23354 ||| -LRB-
26 ||| S:23354 E:23356 ||| CD
] ||| S:23356 E:23357 ||| -RRB-
.  ||| S:23357 E:23371 ||| .
Finally  ||| S:23371 E:23379 ||| RB
the  ||| S:23379 E:23383 ||| DT
5 ||| S:23383 E:23384 ||| CD
'  ||| S:23384 E:23386 ||| POS
arm  ||| S:23386 E:23390 ||| NN
of  ||| S:23390 E:23393 ||| IN
homology  ||| S:23393 E:23402 ||| NN
was  ||| S:23402 E:23406 ||| VBD
provided  ||| S:23406 E:23415 ||| VBN
by  ||| S:23415 E:23418 ||| IN
a  ||| S:23418 E:23420 ||| DT
4.5  ||| S:23420 E:23424 ||| CD
kb  ||| S:23424 E:23439 ||| CD
Xho  ||| S:23439 E:23443 ||| NNS
I  ||| S:23443 E:23445 ||| PRP
fragment  ||| S:23445 E:23454 ||| VBD
of  ||| S:23454 E:23470 ||| IN
Hnf3  ||| S:23470 E:23475 ||| CD
α  ||| S:23475 E:23477 ||| CD
genomic  ||| S:23477 E:23485 ||| JJ
DNA  ||| S:23485 E:23489 ||| NN
that  ||| S:23489 E:23494 ||| WDT
was  ||| S:23494 E:23510 ||| VBD
introduced  ||| S:23510 E:23521 ||| VBN
into  ||| S:23521 E:23526 ||| IN
a  ||| S:23526 E:23528 ||| DT
unique  ||| S:23528 E:23535 ||| JJ
Pac1  ||| S:23535 E:23540 ||| CD
site  ||| S:23540 E:23545 ||| NN
( ||| S:23545 E:23546 ||| -LRB-
blunt ||| S:23546 E:23551 ||| LS
)  ||| S:23551 E:23553 ||| -RRB-
in  ||| S:23553 E:23556 ||| IN
the  ||| S:23556 E:23572 ||| DT
preceding  ||| S:23572 E:23582 ||| JJ
plasmid ||| S:23582 E:23589 ||| NN
.  ||| S:23589 E:23591 ||| .
Importantly ||| S:23591 E:23602 ||| RB
,  ||| S:23602 E:23604 ||| ,
this  ||| S:23604 E:23609 ||| DT
fragment  ||| S:23609 E:23618 ||| NN
extended  ||| S:23618 E:23639 ||| VBN
from  ||| S:23639 E:23644 ||| IN
5 ||| S:23644 E:23645 ||| CD
'  ||| S:23645 E:23647 ||| POS
genomic  ||| S:23647 E:23655 ||| JJ
DNA  ||| S:23655 E:23659 ||| NN
into  ||| S:23659 E:23664 ||| IN
sequences  ||| S:23664 E:23674 ||| NNS
encoding  ||| S:23674 E:23683 ||| VBP
the  ||| S:23683 E:23699 ||| DT
untranslated  ||| S:23699 E:23712 ||| JJ
5 ||| S:23712 E:23713 ||| CD
'  ||| S:23713 E:23715 ||| POS
end  ||| S:23715 E:23719 ||| NN
of  ||| S:23719 E:23735 ||| IN
Hnf3  ||| S:23735 E:23740 ||| CD
α  ||| S:23740 E:23742 ||| JJ
mRNA ||| S:23742 E:23746 ||| NN
.  ||| S:23746 E:23748 ||| .
This  ||| S:23748 E:23753 ||| DT
cloning  ||| S:23753 E:23773 ||| JJ
strategy  ||| S:23773 E:23782 ||| NN
left  ||| S:23782 E:23787 ||| VBD
a  ||| S:23787 E:23789 ||| DT
unique  ||| S:23789 E:23809 ||| JJ
Sal  ||| S:23809 E:23813 ||| NNP
I  ||| S:23813 E:23815 ||| NNP
site  ||| S:23815 E:23820 ||| NN
into  ||| S:23820 E:23825 ||| IN
which  ||| S:23825 E:23831 ||| WDT
coding  ||| S:23831 E:23850 ||| VBZ
sequences  ||| S:23850 E:23860 ||| VBN
of  ||| S:23860 E:23863 ||| IN
transgenes  ||| S:23863 E:23874 ||| NNS
could  ||| S:23874 E:23880 ||| MD
be  ||| S:23880 E:23883 ||| VB
introduced ||| S:23883 E:23893 ||| VBN
.  ||| S:23893 E:23895 ||| .
A  ||| S:23895 E:23897 ||| DT
NotI  ||| S:23897 E:23914 ||| JJ
( ||| S:23914 E:23915 ||| -LRB-
blunt ||| S:23915 E:23920 ||| LS
)  ||| S:23920 E:23922 ||| -RRB-
3.6  ||| S:23922 E:23926 ||| CD
kb  ||| S:23926 E:23929 ||| CD
lacZ  ||| S:23929 E:23934 ||| JJ
fragment  ||| S:23934 E:23943 ||| NN
from  ||| S:23943 E:23948 ||| IN
pCMV-βgal  ||| S:23948 E:23958 ||| NNP
( ||| S:23958 E:23959 ||| -LRB-
Clontech ||| S:23959 E:23967 ||| NNP
)  ||| S:23967 E:23981 ||| -RRB-
was  ||| S:23981 E:23985 ||| VBD
ligated  ||| S:23985 E:23993 ||| VBN
into  ||| S:23993 E:23998 ||| IN
this  ||| S:23998 E:24003 ||| DT
SalI  ||| S:24003 E:24008 ||| JJ
( ||| S:24008 E:24009 ||| -LRB-
blunt ||| S:24009 E:24014 ||| LS
)  ||| S:24014 E:24016 ||| -RRB-
site  ||| S:24016 E:24021 ||| NN
to  ||| S:24021 E:24024 ||| TO
generate  ||| S:24024 E:24033 ||| VB
a  ||| S:24033 E:24047 ||| DT
targeting  ||| S:24047 E:24057 ||| JJ
vector  ||| S:24057 E:24064 ||| NN
that  ||| S:24064 E:24069 ||| WDT
could  ||| S:24069 E:24075 ||| MD
be  ||| S:24075 E:24078 ||| VB
used  ||| S:24078 E:24083 ||| VBN
to  ||| S:24083 E:24086 ||| TO
introduce  ||| S:24086 E:24109 ||| VB
lacZ  ||| S:24109 E:24114 ||| JJ
into  ||| S:24114 E:24119 ||| IN
the  ||| S:24119 E:24123 ||| DT
"marked ||| S:24123 E:24130 ||| NN
"  ||| S:24130 E:24145 ||| ``
Hnf3  ||| S:24145 E:24150 ||| FW
α  ||| S:24150 E:24152 ||| FW
locus ||| S:24152 E:24157 ||| FW
.  ||| S:24157 E:24193 ||| .
Culture  ||| S:24193 E:24201 ||| NN
and  ||| S:24201 E:24205 ||| CC
selection  ||| S:24205 E:24215 ||| NN
of  ||| S:24215 E:24218 ||| IN
embryonic  ||| S:24218 E:24228 ||| JJ
stem  ||| S:24228 E:24233 ||| NN
cell  ||| S:24233 E:24250 ||| NN
lines  ||| S:24250 E:24268 ||| NNS
All  ||| S:24268 E:24272 ||| DT
ES  ||| S:24272 E:24275 ||| NNP
cell  ||| S:24275 E:24280 ||| NN
lines  ||| S:24280 E:24286 ||| NNS
were  ||| S:24286 E:24291 ||| VBD
cultured  ||| S:24291 E:24300 ||| VBN
on  ||| S:24300 E:24303 ||| IN
mitotically  ||| S:24303 E:24327 ||| FW
inactivated  ||| S:24327 E:24339 ||| FW
primary  ||| S:24339 E:24347 ||| FW
embryonic  ||| S:24347 E:24357 ||| FW
fibroblasts  ||| S:24357 E:24369 ||| FW
in  ||| S:24369 E:24372 ||| FW
ES  ||| S:24372 E:24375 ||| FW
cell  ||| S:24375 E:24392 ||| FW
medium  ||| S:24392 E:24399 ||| FW
supplemented  ||| S:24399 E:24412 ||| FW
with  ||| S:24412 E:24417 ||| FW
recombinant  ||| S:24417 E:24429 ||| FW
leukemia  ||| S:24429 E:24450 ||| FW
inhibitory  ||| S:24450 E:24461 ||| FW
factor  ||| S:24461 E:24468 ||| FW
( ||| S:24468 E:24469 ||| -LRB-
LIF ||| S:24469 E:24472 ||| NNP
)  ||| S:24472 E:24474 ||| -RRB-
as  ||| S:24474 E:24477 ||| RB
described  ||| S:24477 E:24487 ||| VBN
elsewhere  ||| S:24487 E:24497 ||| RB
[  ||| S:24497 E:24499 ||| -LRB-
27 ||| S:24499 E:24501 ||| CD
] ||| S:24501 E:24502 ||| -RRB-
.  ||| S:24502 E:24516 ||| .
Gene  ||| S:24516 E:24521 ||| NN
targeting  ||| S:24521 E:24531 ||| NNS
was  ||| S:24531 E:24535 ||| VBD
carried  ||| S:24535 E:24543 ||| VBN
out  ||| S:24543 E:24547 ||| RP
using  ||| S:24547 E:24553 ||| VBG
100  ||| S:24553 E:24557 ||| CD
μg  ||| S:24557 E:24560 ||| NN
of  ||| S:24560 E:24563 ||| IN
linear  ||| S:24563 E:24582 ||| NNS
targeting  ||| S:24582 E:24592 ||| VBG
plasmid ||| S:24592 E:24599 ||| NNS
.  ||| S:24599 E:24601 ||| .
This  ||| S:24601 E:24606 ||| DT
was  ||| S:24606 E:24610 ||| VBD
introduced  ||| S:24610 E:24621 ||| VBN
into  ||| S:24621 E:24626 ||| IN
2.5  ||| S:24626 E:24630 ||| CD
×  ||| S:24630 E:24632 ||| CD
10  ||| S:24632 E:24647 ||| CD
8ES  ||| S:24647 E:24651 ||| CD
cells  ||| S:24651 E:24657 ||| NNS
by  ||| S:24657 E:24660 ||| IN
electroporation  ||| S:24660 E:24676 ||| NN
at  ||| S:24676 E:24679 ||| IN
250  ||| S:24679 E:24695 ||| CD
volts ||| S:24695 E:24700 ||| CD
/ ||| S:24700 E:24701 ||| CD
500μf ||| S:24701 E:24706 ||| CD
/ ||| S:24706 E:24707 ||| CD
resistance  ||| S:24707 E:24718 ||| NN
8  ||| S:24718 E:24720 ||| CD
using  ||| S:24720 E:24726 ||| VBG
a  ||| S:24726 E:24728 ||| DT
BTX  ||| S:24728 E:24732 ||| NNP
ECM600  ||| S:24732 E:24751 ||| NNP
electroporation  ||| S:24751 E:24767 ||| JJ
system ||| S:24767 E:24773 ||| NN
.  ||| S:24773 E:24775 ||| .
Cells  ||| S:24775 E:24781 ||| NNS
were  ||| S:24781 E:24786 ||| VBD
plated  ||| S:24786 E:24793 ||| VBN
on  ||| S:24793 E:24796 ||| IN
thirteen  ||| S:24796 E:24817 ||| CD
10  ||| S:24817 E:24820 ||| CD
cm  ||| S:24820 E:24823 ||| CD
2tissue  ||| S:24823 E:24831 ||| CD
culture  ||| S:24831 E:24839 ||| NN
dishes  ||| S:24839 E:24846 ||| NNS
and  ||| S:24846 E:24850 ||| CC
grown  ||| S:24850 E:24856 ||| VBN
for  ||| S:24856 E:24860 ||| IN
two  ||| S:24860 E:24864 ||| CD
days  ||| S:24864 E:24869 ||| NNS
in  ||| S:24869 E:24884 ||| IN
ES  ||| S:24884 E:24887 ||| NNP
cell  ||| S:24887 E:24892 ||| NN
medium  ||| S:24892 E:24899 ||| NN
supplemented  ||| S:24899 E:24912 ||| NN
with  ||| S:24912 E:24917 ||| IN
LIF ||| S:24917 E:24920 ||| NNP
.  ||| S:24920 E:24922 ||| .
Cells  ||| S:24922 E:24928 ||| NNS
containing  ||| S:24928 E:24952 ||| VBG
Neo  ||| S:24952 E:24956 ||| NNP
were  ||| S:24956 E:24961 ||| VBD
selected  ||| S:24961 E:24970 ||| VBN
by  ||| S:24970 E:24985 ||| IN
supplementing  ||| S:24985 E:24999 ||| VBG
the  ||| S:24999 E:25003 ||| DT
ES  ||| S:25003 E:25006 ||| NNP
cell  ||| S:25006 E:25011 ||| NN
medium  ||| S:25011 E:25018 ||| NN
with  ||| S:25018 E:25023 ||| IN
300  ||| S:25023 E:25027 ||| CD
μg ||| S:25027 E:25029 ||| FW
/ ||| S:25029 E:25030 ||| FW
ml  ||| S:25030 E:25045 ||| FW
Geneticin  ||| S:25045 E:25055 ||| FW
( ||| S:25055 E:25056 ||| -LRB-
G418 ||| S:25056 E:25060 ||| NNP
, ||| S:25060 E:25061 ||| ,
Gibco-BRL ||| S:25061 E:25070 ||| NNP
)  ||| S:25070 E:25072 ||| -RRB-
and  ||| S:25072 E:25076 ||| CC
negative  ||| S:25076 E:25085 ||| JJ
selection  ||| S:25085 E:25107 ||| NN
against  ||| S:25107 E:25128 ||| IN
Hsv-tk  ||| S:25128 E:25135 ||| JJ
gene  ||| S:25135 E:25140 ||| NN
expression  ||| S:25140 E:25151 ||| NN
was  ||| S:25151 E:25167 ||| VBD
achieved  ||| S:25167 E:25176 ||| VBN
by  ||| S:25176 E:25179 ||| IN
including  ||| S:25179 E:25189 ||| VBG
2  ||| S:25189 E:25191 ||| CD
μM  ||| S:25191 E:25194 ||| JJ
gancyclovir  ||| S:25194 E:25206 ||| NNS
( ||| S:25206 E:25207 ||| -LRB-
Roche ||| S:25207 E:25212 ||| NNP
) ||| S:25212 E:25213 ||| -RRB-
.  ||| S:25213 E:25227 ||| .
Recombination  ||| S:25227 E:25241 ||| NNP
between  ||| S:25241 E:25262 ||| IN
loxP  ||| S:25262 E:25267 ||| JJ
elements  ||| S:25267 E:25276 ||| NNS
in  ||| S:25276 E:25279 ||| IN
ES  ||| S:25279 E:25282 ||| NNP
cells  ||| S:25282 E:25288 ||| NNS
was  ||| S:25288 E:25304 ||| VBD
mediated  ||| S:25304 E:25313 ||| VBN
by  ||| S:25313 E:25316 ||| IN
introducing  ||| S:25316 E:25328 ||| VBG
a  ||| S:25328 E:25330 ||| DT
Cre  ||| S:25330 E:25334 ||| JJ
expression  ||| S:25334 E:25345 ||| NN
plasmid ||| S:25345 E:25352 ||| NN
,  ||| S:25352 E:25366 ||| ,
pHDMCCre8  ||| S:25366 E:25376 ||| NNP
( ||| S:25376 E:25377 ||| -LRB-
provided  ||| S:25377 E:25386 ||| VBN
by  ||| S:25386 E:25389 ||| IN
Dr.  ||| S:25389 E:25393 ||| NNP
Klaus  ||| S:25393 E:25399 ||| NNP
Kaestner ||| S:25399 E:25407 ||| NNP
) ||| S:25407 E:25408 ||| -RRB-
.  ||| S:25408 E:25410 ||| .
100  ||| S:25410 E:25414 ||| CD
μg  ||| S:25414 E:25417 ||| NN
of  ||| S:25417 E:25432 ||| IN
pHDMCCre8  ||| S:25432 E:25442 ||| NNP
was  ||| S:25442 E:25446 ||| VBD
introduced  ||| S:25446 E:25457 ||| VBN
into  ||| S:25457 E:25462 ||| IN
5  ||| S:25462 E:25464 ||| CD
×  ||| S:25464 E:25466 ||| CD
10  ||| S:25466 E:25469 ||| CD
7ES  ||| S:25469 E:25473 ||| CD
cells  ||| S:25473 E:25479 ||| NNS
by  ||| S:25479 E:25494 ||| IN
electroporation  ||| S:25494 E:25510 ||| NNS
using  ||| S:25510 E:25516 ||| VBG
400  ||| S:25516 E:25520 ||| CD
v ||| S:25520 E:25521 ||| CD
/ ||| S:25521 E:25522 ||| CD
500μf ||| S:25522 E:25527 ||| CD
/ ||| S:25527 E:25528 ||| CD
resistance  ||| S:25528 E:25539 ||| NN
setting  ||| S:25539 E:25547 ||| VBG
8.  ||| S:25547 E:25562 ||| CD
1 ||| S:25562 E:25563 ||| CD
/ ||| S:25563 E:25564 ||| CD
100,000  ||| S:25564 E:25572 ||| CD
of  ||| S:25572 E:25575 ||| IN
the  ||| S:25575 E:25579 ||| DT
total  ||| S:25579 E:25585 ||| JJ
electroporated  ||| S:25585 E:25600 ||| JJ
cell  ||| S:25600 E:25605 ||| NN
population  ||| S:25605 E:25628 ||| NN
was  ||| S:25628 E:25632 ||| VBD
plated  ||| S:25632 E:25639 ||| VBN
per  ||| S:25639 E:25643 ||| IN
10  ||| S:25643 E:25646 ||| CD
cm  ||| S:25646 E:25649 ||| CD
2tissue  ||| S:25649 E:25657 ||| CD
culture  ||| S:25657 E:25665 ||| NN
dish  ||| S:25665 E:25670 ||| NN
in  ||| S:25670 E:25673 ||| IN
ES  ||| S:25673 E:25676 ||| NNP
cell  ||| S:25676 E:25693 ||| NN
medium  ||| S:25693 E:25700 ||| NN
supplemented  ||| S:25700 E:25713 ||| NN
with  ||| S:25713 E:25718 ||| IN
LIF  ||| S:25718 E:25722 ||| NNP
and  ||| S:25722 E:25726 ||| CC
grown  ||| S:25726 E:25732 ||| VBN
until  ||| S:25732 E:25738 ||| IN
individual  ||| S:25738 E:25761 ||| JJ
colonies  ||| S:25761 E:25770 ||| NNS
could  ||| S:25770 E:25776 ||| MD
be  ||| S:25776 E:25779 ||| VB
collected ||| S:25779 E:25788 ||| VBN
.  ||| S:25788 E:25824 ||| .
Tetraploid  ||| S:25824 E:25835 ||| JJ
aggregation  ||| S:25835 E:25847 ||| NN
and  ||| S:25847 E:25851 ||| CC
β-galactosidase  ||| S:25851 E:25879 ||| JJ
staining  ||| S:25879 E:25900 ||| JJ
Embryos  ||| S:25900 E:25908 ||| NNP
were  ||| S:25908 E:25913 ||| VBD
generated  ||| S:25913 E:25923 ||| VBN
from  ||| S:25923 E:25928 ||| IN
ES  ||| S:25928 E:25931 ||| NNP
cells  ||| S:25931 E:25937 ||| NNS
by  ||| S:25937 E:25940 ||| IN
aggregating  ||| S:25940 E:25964 ||| VBG
them  ||| S:25964 E:25969 ||| PRP
with  ||| S:25969 E:25974 ||| IN
4-cell  ||| S:25974 E:25981 ||| CD
stage  ||| S:25981 E:25987 ||| NN
embryos  ||| S:25987 E:25995 ||| NNS
made  ||| S:25995 E:26000 ||| VBD
tetraploid  ||| S:26000 E:26011 ||| VBN
by  ||| S:26011 E:26026 ||| IN
electrofusion ||| S:26026 E:26039 ||| NN
,  ||| S:26039 E:26041 ||| ,
as  ||| S:26041 E:26044 ||| RB
described  ||| S:26044 E:26054 ||| VBN
previously  ||| S:26054 E:26065 ||| RB
[  ||| S:26065 E:26067 ||| -LRB-
19 ||| S:26067 E:26069 ||| CD
,  ||| S:26069 E:26071 ||| ,
20 ||| S:26071 E:26073 ||| CD
,  ||| S:26073 E:26075 ||| ,
27 ||| S:26075 E:26077 ||| CD
] ||| S:26077 E:26078 ||| -RRB-
.  ||| S:26078 E:26092 ||| .
Aggregates  ||| S:26092 E:26103 ||| NNS
that  ||| S:26103 E:26108 ||| WDT
formed  ||| S:26108 E:26115 ||| VBD
blastocysts  ||| S:26115 E:26127 ||| VBN
after  ||| S:26127 E:26133 ||| IN
overnight  ||| S:26133 E:26155 ||| JJ
culture  ||| S:26155 E:26163 ||| NN
were  ||| S:26163 E:26168 ||| VBD
allowed  ||| S:26168 E:26176 ||| VBN
to  ||| S:26176 E:26179 ||| TO
continue  ||| S:26179 E:26188 ||| VB
their  ||| S:26188 E:26194 ||| PRP$
development  ||| S:26194 E:26219 ||| NN
in  ||| S:26219 E:26222 ||| IN
utero  ||| S:26222 E:26228 ||| NN
by  ||| S:26228 E:26231 ||| IN
transferring  ||| S:26231 E:26244 ||| VBG
them  ||| S:26244 E:26249 ||| PRP
to  ||| S:26249 E:26264 ||| TO
a  ||| S:26264 E:26266 ||| DT
pseudopregnant  ||| S:26266 E:26281 ||| JJ
surrogate  ||| S:26281 E:26291 ||| JJ
mother ||| S:26291 E:26297 ||| NN
.  ||| S:26297 E:26299 ||| .
Embryos  ||| S:26299 E:26307 ||| NNP
were  ||| S:26307 E:26312 ||| VBD
stained  ||| S:26312 E:26332 ||| VBN
for  ||| S:26332 E:26336 ||| IN
expression  ||| S:26336 E:26347 ||| NN
of  ||| S:26347 E:26350 ||| IN
β-galactosidase  ||| S:26350 E:26366 ||| JJ
using  ||| S:26366 E:26372 ||| VBG
standard  ||| S:26372 E:26393 ||| JJ
techniques  ||| S:26393 E:26404 ||| NNS
[  ||| S:26404 E:26406 ||| -LRB-
28 ||| S:26406 E:26408 ||| CD
] ||| S:26408 E:26409 ||| -RRB-
.  ||| S:26409 E:26453 ||| .
Abbreviations  ||| S:26453 E:26475 ||| NNP
Neo  ||| S:26475 E:26479 ||| NNP
-  ||| S:26479 E:26481 ||| :
neomycin  ||| S:26481 E:26490 ||| FW
phosphotransferase  ||| S:26490 E:26517 ||| FW
pgk  ||| S:26517 E:26521 ||| FW
-  ||| S:26521 E:26523 ||| :
phosphoglycerate  ||| S:26523 E:26540 ||| FW
kinase  ||| S:26540 E:26547 ||| FW
promoter  ||| S:26547 E:26564 ||| FW
Hsv-TK  ||| S:26564 E:26571 ||| FW
-  ||| S:26571 E:26573 ||| :
Herpes  ||| S:26573 E:26580 ||| FW
simplex  ||| S:26580 E:26588 ||| FW
virus  ||| S:26588 E:26594 ||| FW
thymidine  ||| S:26594 E:26604 ||| FW
kinase  ||| S:26604 E:26619 ||| FW
Hnf  ||| S:26619 E:26623 ||| FW
-  ||| S:26623 E:26625 ||| :
hepatocyte  ||| S:26625 E:26636 ||| JJ
nuclear  ||| S:26636 E:26644 ||| JJ
factor  ||| S:26644 E:26659 ||| NN
LIF  ||| S:26659 E:26663 ||| NNP
-  ||| S:26663 E:26665 ||| :
leukemia  ||| S:26665 E:26674 ||| FW
inhibitory  ||| S:26674 E:26685 ||| FW
factor  ||| S:26685 E:26700 ||| FW
HPRT  ||| S:26700 E:26705 ||| FW
-  ||| S:26705 E:26707 ||| :
hydroxyphosphoribosyl  ||| S:26707 E:26729 ||| FW
transferase  ||| S:26729 E:26756 ||| FW
